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0 SUMMARY /  INTRODUCTION 
The 2016 Scoreboard sample comprises 590 
companies based in the EU, 837 companies 
based in the US, 356 in Japan, 327 in China 
and 390 from the rest of the world. 
Summary
The "EU Industrial R&D Investment Scoreboard" 
(the Scoreboard), published annually since 2004, 
monitors top EU based R&D investing companies 
benchmarking them with top R&D investors located 
in other parts of the world. The Scoreboard is part 
of the European Commission’s monitoring activities 
to improve the understanding of trends in R&D 
investment by the business sector. In the context of 
the EU agenda for Jobs, Growth and Investment, the 
contribution of the business sector to reach the 3% 
objective for R&D intensity in the European economy 
is crucial. Evidence from the Scoreboard shows that 
most of the EU R&D gap with respect to main world 
competitors comes from an insufficient number 
of leading innovative companies in key high-tech 
sectors. The Scoreboard shows the details of how 
this gap is made up from the differing contributions 
of individual R&D companies.
The Scoreboard relies on economic and financial information 
on the World's top 2500 companies that invested €696 billion 
in R&D –representing about 90% of the total expenditure on 
R&D financed by the business sector worldwide. The data 
is collected from the latest available companies' accounts 
(i.e. for this year's edition usually the fiscal year 2015/161). 
It complements official territorial statistics (such as BERD) 
in the study of important questions related to companies' 
innovation behaviour in a global context. It is a reliable, up-to-
date benchmarking tool for comparisons between companies, 
industries, and geographical areas, as well as to monitor and 
analyse the scale and dynamics of industrial R&D. 
This Scoreboard edition shows important variations of 
companies' R&D investments and economic results across 
countries and industries. This reflects the persistent market 
and economic uncertainties and opportunities in which 
global R&D companies continued to operate in 2015/16.
 1 The latest available annual account is taken into account for each individual company. Due to differences in accounting practices, however, these refer to a range of 
dates from late 2014 to the first half year of 2016 (see methodological notes in Annex 2).
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Highlights
In 2015/16, the world top 2500 R&D Scoreboard companies invested a total of €696bn in R&D, 
an increase of 6.6% over the previous year, driven by the R&D growth in high tech industries. In 
contrast, companies’ net sales declined (-3.7%), mostly due to low-tech sectors and particularly 
to oil-related companies.
The group of EU companies within the top 2500 increased their R&D by 7.5%, above the rate of 
the US companies at 5.9% and the Japanese companies at 3.3%. 
In contrast to the increases in R&D, the combined sales of the EU group fell by 3.6%, the 
US group fell by 4.0% but sales rose by 0.3% for the Japanese group. The sales decreases 
were driven by low world oil and commodity prices which reduced the sales of oil and mining 
companies which have modest R&D investments but large sales. Japan has no large companies 
operating in these sectors. For the same reason, overall operating profits fell for both the EU 
and US groups.
As in the past few years, companies based in China continued to show the best performance 
in terms of R&D growth (up by 24.7%) but presented also a significant decrease in net sales 
(-6.2%). Companies based in South Korea and Taiwan showed a more modest R&D growth and 
also a slight decrease in net sales.
Global R&D is concentrated with the top 100 global R&D investors accounting for 53.1% of the 
R&D of the whole top 2500 and the top 50 companies accounting for 40%. There are 15 EU 
companies in the top 50 with 23 from the US, 4 from Japan, 3 each from China and Switzerland 
and one each from South Korea and Taiwan.
The top 50 large companies listed by R&D intensity (R&D to sales ratio) are dominated by the 
high tech sectors of biotechnology & pharmaceuticals, software and technology hardware. The 
US is very strong in these three sectors and accounts for eight of the top 10 companies in the 
top 50. These three sectors are the global top three by R&D growth, in the top four for sales 
growth and at the top for profitability.
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The largest groups of companies in the world top 2500 companies are drawn from the ICT 
(information, communications and telecoms industries), health care and automotive industries. 
However, the sector mix or specialisation of the various world regions is very different. The US 
has 69% of its R&D in its top three sectors of biopharmaceuticals, software and technology 
hardware whereas both the EU and Japan have automotive as their top sector by amount of 
R&D. Software is only the eighth largest sector in the EU and the ninth in Japan.
These substantial sector mix differences explain why the overall R&D intensity of the US group 
is 5.8% compared to only 3.2% for the EU companies. It is also why overall EU profitability at 
6.8% is much lower than for the US with 12.9%. The gap in the proportions of highly intensive 
R&D has widened over the last ten years because of the outperformance of the US’s ICT and 
biotech sectors. For example, the US software sector has doubled its proportion of US R&D over 
the last 10 years.
The Scoreboard also contains details of the top 1000 EU R&D investors which comprise the 
590 in the global set together with an additional 410 with R&D down to €6m. The EU 1000 
contains 274 firms from the UK, 217 from Germany, 117 from France and 392 from 19 other 
EU countries. The 906 firms based in the top 10 member states showed an R&D increase of 
7.4% over the previous year.
The 2016 Scoreboard also contains chapters analysing the dynamics of company growth over 
the last 12 years, industrial R&D flows across borders and the effect of mergers and acquisitions 
on transfer of R&D between countries.
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Significant worldwide rise of corporate R&D, driven by high-tech industries, while 
revenues declined mostly due to the challenging environment in which many low-
tech sectors operated
 
FIGURE S.1 – WORLDWIDE GROWTH RATE OF R&D AND NET SALES OVER THE PERIOD 2011-2015.  
Note: Figures for 1622 out of the 2500 companies for which R&D and net sales are available for the 10 years period.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
EU companies increased R&D above both the world’s and US’s growth rates
Key findings
The top 2500 Scoreboard companies invested in R&D 
€696.0bn in 2015/16, an increase of 6.6% with respect 
to 2014/15, a similar growth rate to the year before 
(6.8%). In contrast, companies' net sales declined 
(-3.6%), compared with an increase of 2.2% in 2014/15 
(see Figure S1 and Table S1).
The companies based in the EU increased R&D 
investment at a higher rate than the world’s average, 
at 7.5% while decreasing net sales (-3.6%). The same 
trend of robust R&D investment growth rates coupled 
with net sales decline is observed for companies 
located in other world regions. Companies based in 
China continued to show outstanding growth rates for 
R&D (24.7%), but the decline in net sales is also the 
highest among main regions (-6.2%). US companies 
reported a significant increase in R&D (5.9%) but 
below the one observed for EU ones. The Japanese 
companies showed a modest R&D increase (3.3%) 
while net sales remained practically unchanged (see 
Table S.1). 
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TABLE S.1 - OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2016 SCOREBOARD. 
Note : The RoW group comprises companies based in Taiwan, South Korea, Switzerland, Canada and a further 19 countries.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor Global EU USA Japan China RoW
No. of 
companies 2 500 590 837 356 327 390
R&D IN 
2015/16, €bn 696.0 188.3 268.6 99.9 49.8 89.4
World R&D 
share, % 100.0 27.1 38.6 14.4 7.2 12.8
One year 
change, % 6.6 7.5 5.9 3.3 24.7 2.4
Net Sales, €bn 17 686.8 5 678.4 4 518.8 2 859.6 1 978.9  2 651.2
World net sales 
share, % 100.0 32.1 25.5 16.2 11.2 15.0
One year 
change, % -3.6 -3.6 -4.0 0.3 -6.2 -4.8
R&D 
intensity, % 3.8 3.2 5.8 3.3 2.5 3.3
In all world regions, the growth in R&D was driven by 
companies operating in the largest R&D-investing 
industries (ICT, health and auto), that also increased 
significantly net sales, while the overall fall in net sales 
was mostly due low-tech sectors and in particular due to 
oil- and other commodity-related companies where world 
prices were depressed (see Figure S.2). 
FIGURE S.2 – WORLDWIDE GROWTH RATE OF R&D AND NET SALES IN 2015/16 BY MAIN WORLD REGION AND TWO GROUPS 
OF CHARACTERISTIC R&D INTENSITY. 
Note: R&D figures for the top 2500 R&D investors and net sales for 2240 companies reporting sales in 2014 and 2015.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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R&D investment performance of companies located in other world regions was 
mixed
Companies from South Korea and Taiwan continue to 
show positive R&D growth, while those in Switzerland 
and Canada show a decline. These trends in R&D are 
accompanied in all cases by a decline in net sales, except 
for companies based in Canada (see Table S.2).
TABLE S.2 - PERFORMANCE OF COMPANIES BASED IN THE LARGEST COUNTRIES OF THE RoW GROUP. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor Switzerland South Korea Taiwan Canada
No. of companies 58 75 111 32
R&D in 2015/16, €bn 28.0 25.4 14.0 4.7 
Worl R&D share, % 4.0 3.7 2.0 0.7
One year change, % -1.5 3.7 7.1 -2.3
Net Sales, €bn 377.6 822.5 511.9 115.1
One year change, % -3.3 -1.7 -0.3 1.7
R&D intensity, % 7.4 3.1 2.7 4.1
An important number of players among the top industrial R&D investors are based 
in the EU
Among the top 50 R&D investors (by amount of R&D) 
there are 15 EU companies, the same number as in last 
year’s ranking and 30 companies among the top 100, 
one more than last year. 
For the third consecutive year, the two top R&D investors 
remain the same (Figure S.3): Volkswagen (€13.6bn) from 
Germany in 1st place and Samsung Electronics (€12.5bn) 
from South Korea in 2nd position. The other companies in 
the top-ten are Intel, Alphabet and Microsoft (€11.0bn) 
from the US; Novartis (€9.0bn) and Roche (€8.6bn) from 
Switzerland; Huawei (€8.4bn) from China; Johnson & 
Johnson (€8.3bn) from the US and Toyota Motor (€8.0bn) 
from Japan.
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The Software industry showed the highest R&D growth worldwide, led by global software 
firms 
FIGURE S.3 – TOP 10 COMPANIES OF THE 2016 SCOREBOARD. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
The Software sector showed the highest one-year R&D 
growth rate (12.3%) followed by Pharma (9.8%), IT 
hardware (7.6%) and Auto (6.7%) (see Table S.3). The 
performance of the Software sector is mostly due to the 
R&D growth of US companies such as Alphabet (22.4%) 
and Facebook (80.6%) and Chinese companies such 
Baidu (46.2%). The German company SAP (16.6%) is 
the fourth contributor to the R&D growth of this sector.
TABLE S.3 – RANKING OF TOP 11 INDUSTRIAL SECTORS BY ONE-YEAR R&D GROWTH IN THE 2016 SCOREBOARD. 
Note: The numbers in brackets indicate the relative R&D size of the sector (% of world sector R&D)
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
sector Global R&D Growth (%) EU USA Japan China
Software & Computer Services 12.3 12.2 (9) 11.5 (77) -8.3 (3) 38.3 (7)
Pharma & Biotechnology 9.8 13.2 (28) 13.0 (46) 2.3 (8) 27.5 (1)
Technology Hardware & Equip. 7.6 0.0 (14) 5.1 (57) 4.7 (6) 35.0 (13)
Automobile & Parts 6.7 9.2 (46) -0.6 (15) 5.5 (27) 14.2 (4)
Electronic & Electrical Equipment 5.5 9.6 (19) 3.1 (13) 3.7 (25) 23.7 (6)
Health Care Equip.  
& Services 5.0 20.7 (32) -3.1 (55) 10.9 (9) 14.1 (2)
General Industrials 3.7 10.6 (19) 0.5 (39) 0.6 (30) 14.7 (7)
Industrial Engineering 3.3 -1.7 (32) -1,4 (26) 9.6 (14) 24.8 (16)
Leisure Goods 2.9 7.5 (1) 13.0 (10) 0.2 (61) 15.8 (3)
Chemicals 2.3 6.7 (23) -3.8 (31) 5.0 (30) 28.0 (2)
Aerospace & Defence 1.2 -0.8 (46) 2.8 (39) 2.0 (0) 44.7 (1)
Top 11 Industries 7.3 8.2 (25) 7.0 (41) 3.7 (15) 28.6 (6)
Other Industries 1.8 4.6 (39) -6.8 (22) -0.1 (11) 15.4 (15)
All Industries 6.6 7.5 (27) 5.9 (39) 3.3 (14) 24.7 (7)
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TABLE S.4 - PERFORMANCE OF COMPANIES BASED IN THE LARGEST R&D COUNTRIES OF THE EU. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
R&D growth of EU companies is driven by the automobile and high-tech sectors - 
mostly by German companies – while growth of net sales is held back by low-tech 
sectors 
Within the EU, most of the top R&D investing sectors 
showed high R&D growth (excepting IT hardware). 
The highest contribution to R&D growth was shown by 
Automobiles & Parts (9.2%), driven by Daimler (15.6%) 
and BMW (13.2%). Pharmaceuticals & Biotechnology 
was the second highest R&D growth contributor (13.2%) 
with big pharma companies showing very high R&D 
growth (excepting GlaxoSmithKline, -0.5%), e.g. Allergan 
(146.6% due to acquisition), Bayer (20.2%), Boehringer 
(13.2%), AstraZeneca (12.3%) and Sanofi (9.0%). 
Other EU sectors showing double-digit R&D growth are 
Health Care Equipment & Services (20.7% with a large 
acquisition component), Software & Computer Services 
(12.2%) and General Industrials (10.6%).
By member state, the companies based in Germany, 
accounting respectively for 37.6% and 30.0% of the EU’s 
total R&D and net sales, made the largest contribution to 
the performance of the EU group. The German companies 
increased R&D by 10.6% and net sales by 8.7%. The other 
two largest member states of the EU showed a mixed 
performance. Companies based in the UK increased R&D 
by 4.1% but reduced sales significantly (-22%), mostly due 
to the fall in world prices for Oil and Mining companies. 
Companies based in France increased modestly R&D 
(2.0%) and reduced net sales (-3.4%) (see Table S.4). 
R&D of companies based in Ireland (29.5%), made also 
an important contribution to the EU group, though most 
of the R&D increase comes from a few American health-
related companies with registered offices in Ireland.
Factor Germany UK France The Netherlands
No. of companies 132 133 83 38
R&D in 2015-2016, 
€bn 69.8 27.1 28.5 14.1
World R&D share, % 10.0 4.1 4.1 2.0
One year change, % 10.6 4.1 2.0 4.1
Net Sales, €bn 1 714.1 1 069.3 1 015.9 368.5
One year change, % 8.7 -22.0 -3.4 1.1
R&D intensity, % 3.9 2.5 2.8 3.8
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R&D growth of non-EU companies is dominated by high-tech sectors – mostly by US 
and Chinese companies – while growth of net sales greatly varied across sectors and 
countries
The US companies showed a significant increase in 
R&D in high-tech sectors such as Pharma (13.0%) and 
Software (11.5%) but presented poor results in terms 
of net sales (-0.2% in Auto, 1.6% in Software and 4.1% 
in Pharma).
Japanese companies underperformed EU and US 
firms in terms of R&D growth (3.3%) but showed 
better results in terms of net sales growth (0.2%). The 
performance of Japanese companies is led by the Auto 
sector that showed an increase of 5.5% in R&D and 
6.5% in net sales in 2015.
In the Chinese group of companies, outstanding 
performance was shown by ICT-related companies 
Huawei, ZTE and Baidu that grew R&D by more than 
30% and also net sales by more than 20%. (see Table 
S.3).
The EU-US R&D intensity gap has increased over the past 10 years, mostly due to 
the outperformance of ICT industries in the US
In 2015/16, the US invested almost twice as much 
of its Scoreboard R&D in high tech sectors compared 
to the EU (75% vs 40%) whereas the EU had more 
than twice of its Scoreboard R&D in medium-high tech 
sectors (45% vs 20%). This difference in specialisation 
explains the overall EU-US R&D intensity gap that has 
widened over the years, especially due to the high 
R&D growth of US companies in the ICT sector and 
particularly in Software-related industries. As shown 
in figure S.4 (page 18), the US software sector has 
almost doubled its proportion of US R&D from 2006 to 
2016. On the other hand, the automotive proportion of 
total R&D in the US has shrunk while it has increased 
in the EU.
A statistical analysis on the dynamics of companies' R&D over the last 12 years 
shows characteristic patterns and persistence of the R&D growth process
Scoreboard companies have heterogeneous growth paths 
of R&D, even when comparing companies in the same 
sector. Most firms have a positive but modest growth rate 
of R&D investment from one year to the next. However, in 
each year a handful of firms experience rapid growth or 
decline of R&D. Focusing on large firms that experienced 
high R&D performance shows that rapid R&D growth is 
observed across all industries.
Companies' R&D growth reacted to the financial crisis 
in different ways -some companies even appear to be 
quite unaffected. Moderate persistence in R&D dynamics 
means that companies that grew (declined) in one year 
are likely to continue to grow (decline) in the next.
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An analysis combining R&D and patent data on the parent companies and their 
subsidiaries improves our understanding of the scale and dynamics of industrial 
R&D flows across territorial borders
On average, companies headquartered in the EU 
allocate about 1/4 of their R&D investments outside the 
EU. The inward R&D from foreign affiliates operating 
in the EU is slightly lower than the outward R&D by 
EU companies. The EU-US R&D flows are the largest 
interregional R&D flows and Switzerland is the second 
most important source of EU inward R&D. Among EU 
Member States, the UK shows the highest outward R&D. 
The analysis by sector shows that Health Industries 
have the highest volumes of inward and outward R&D 
flows, while in Aerospace and Defence and Automobiles 
R&D is mostly performed at home. The EU has a small 
negative R&D balance in the Automobiles sector, 
however representing less than 3% of that sector's 
R&D investment performed at home (see Table S.5).
FIGURE S.4 – RELATIVE SECTOR SPECIALISATION OF THE EU VS THE US IN THE 2006 AND 2016 SCOREBOARDS. 
Note: For the 456 EU and 614 US companies with data available for all the ten years. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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An analysis of Scoreboard companies' mergers and acquisitions (M&A) activity 
over the period 2003-2012 shows that the fear that M&A activity transfers EU 
domestic competencies into foreign hands is excessive 
Results from this analysis show that the majority of 
M&A deals involve US and EU based companies. 
While it is true that US companies are the most active 
acquirers of European firms (particularly from the UK), 
the same holds for EU companies. However, it is true that 
different M&A strategies may explain discrepancies in 
firm performance. In particular, US companies tend to 
focus their M&A strategy on the acquisition of younger 
firms, which generally show higher level of productivity 
and R&D growth. This is a strategy also followed in the 
case of EU based acquiring firms, though to a lesser 
extent than observed for US ones. Overall, these results 
confirm that M&A is an important way for top R&D 
investors to quickly acquire technology capabilities and 
new product lines to expand their knowledge base and 
product range.
TABLE S.5 – ESTIMATED INWARD AND OUTWARD R&D FLOWS FOR MAIN EU INDUSTRIES. 
Note: Data for the period 2011-2013 from the Scoreboard and PATSTAT 2016 spring version.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
sector
eu r&d flows (€m) eu r&d balance (€m)
Home Outward (O) Inward (I) (I-O)
Aerospace & Defence 7 616 1 514 1 661 146
Automobiles 33 071 5 135 4 217 -918
Chemical 3 630 1 136 1 541 405
Health Industries 19 614 10 036 13 507 3 471
ICT Producers 16 587 7 127 7 439 312
ICT Services 7 266 2 007 2 914 908
Industrials 9 984 3 956 3 959 3
Other Sectors 14 272 8 744 4 194 -4 551
Total 112 040 39 656 39 432 -224
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Introduction
The 2016 edition of the “EU Industrial R&D Investment Sco-
reboard” (the Scoreboard)2 comprises the 2500 companies 
investing the largest sums in R&D in the world (€21m 
or more in each case) and an additional number of com-
panies to cover the top 1000 R&D investing companies 
based in the EU3 (R&D of €6m or more). In total, there are 
2909 companies incorporated in the 2016 Scoreboard.
In order to avoid double counting, The Scoreboard considers 
only data from parent or independent companies. Normally, 
these companies integrate into their consolidated accounts 
the data of all their subsidiary companies. An analysis of 
the ownership structure of the parent companies included in 
the 2015 Scoreboard shows that they have about 700.000 
subsidiary companies (controlled companies with more than 
50% ownership).
Companies' R&D rankings are based on information taken 
from the companies’ latest published accounts. For most 
companies these correspond to calendar year 2015, but 
significant proportions have financial years ending on 31 
March 2016 (Japanese companies in particular). There are 
few companies included with financial years ending as late 
as end June 2016 and a few, usually private, for which only 
accounts to end 2014 were available.
The 2016 Scoreboard includes companies based in 45 
countries of which 19 are member states of the EU. A wide 
range of manufacturing and services sectors is represen-
ted, including more than 50 industries with a special focus 
on the most innovative ones such as ICT, health, transport 
and engineering related industries. It should be noted that 
the Scoreboard relies on disclosure of R&D investment in 
companies' published annual reports and accounts and 
that due to different national accounting and disclosure 
practices, companies of some countries are less likely than 
others to disclose R&D investment consistently. For these 
reasons, companies from some countries such as those 
in Southern or Eastern Europe might be under-represen-
ted while others such as companies from the UK could be 
over-represented. 
The overall coverage in terms of R&D is similar to previous 
editions. The total amount of R&D investment of compa-
nies included in the Scoreboard (€696 billion) is equivalent 
to more than 90% of the total expenditure on R&D financed 
and performed by the business sector worldwide4 . 
The Scoreboard collects key information to enable the as-
sessment of the R&D and economic performance of compa-
nies. The main indicators, namely R&D investment, net sales, 
capital expenditures, operating profits and number of em-
ployees are collected following the same methodology, de-
finitions and assumptions applied in previous editions. This 
ensures comparability so that the companies' economic and 
financial data can be analysed over a longer period of time. 
The capacity of data collection is being improved by gathe-
ring information about the ownership structure of the Sco-
reboard parent companies and the main indicators for their 
subsidiaries. In 2016, we have collected available indicators 
reported by about 700.000 subsidiary companies involved 
in this Scoreboard edition. This allows a better characterisa-
tion of companies, in particular regarding the sectoral and 
geographic distribution of their research and production ac-
tivities and the related patterns of growth and employment. 
As shown in last year's Scoreboard, the analysis of key in-
dicators such as patent data of parent companies and their 
subsidiaries allows the reassignment of companies to coun-
tries where they perform the majority of their actual econo-
mic or innovation activity. 
In this edition we continue to improve the characterisation 
of the location of companies' innovation activity. The inter-
nationalisation of R&D is analysed by examining the patent 
activity and the location of the subsidiaries of the Score-
board companies. 
The data have been collected by Bureau van Dijk Electronic 
Publishing GmbH, following thwe same approach and me-
thodology applied since the first Scoreboard edition in 2004. 
For background information please see Annex 1.
2 The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (JRC-IPTS/DG RTD) as part of its Industrial Research and Innovation Monito-
ring and Analysis activity (IRIMA).  
3 In this report, the term EU company refers to companies whose ultimate parent has its registered office in a Member State of the EU. Likewise, non-EU company applies 
when the ultimate parent company is located outside the EU (see also the glossary and definitions in Annex 2 as well as the handling of parent companies and subsidiaries). 
4 According to the latest figures reported by Eurostat, i.e. BERD financed by the business enterprise sector in 2014 compared with R&D figures in the 2015 Scoreboard (see 
Figure I.1 below).
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Description of the company dataset 
This edition of the Scoreboard contains data on the world's 
top 2500 companies ranked by their investments in R&D. 
These companies each invested more than €21 million in 
2015/16, accounting together for total R&D of €696.0 billion. 
The amount of R&D investment by these 2500 companies 
is equivalent to more than 55% of the total expenditure on 
R&D worldwide (GERD) and about 90% of the R&D expen-
diture financed by the business sector worldwide (BERD). 
This is illustrated in figure I.1 where the latest 2014 terri-
torial statistics are compared with the corresponding figu-
res of the 2015 Scoreboard (Scoreboard €607.2bn; GERD 
€1086.9bn; BERD €679.7bn).
FIGURE I.1 - COMPARISON OF R&D FIGURES OF THE SCOREBOARD AND TERRITORIAL STATISTICS. 
Note: Total R&D expenditure (GERD) and total business R&D expenditure (BERD) funded by the business sector in 2014.
Sources: Adapted from latest figures reported by Eurostat on 30 November 2016, including most countries reporting R&D.
The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The dataset is complemented with additional companies 
in order to cover the top 1000 R&D investing companies 
based in the EU, all of them having invested more than 
R&D €6 million in 2015/16. This additional sample is 
analysed separately in chapter 4. 
The main methodological limitations are summarised in 
Box I.1 (see further description of the dataset in Annex 2).
Companies' distribution by country and industry
The 2016 Scoreboard comprises 2500 companies with 
headquarters in 45 countries of which 19 are member 
states of the EU. The sample includes companies based 
in the EU (590), the US (837), Japan (356), China (327), 
Taiwan (111), South Korea (75), Switzerland (58), Canada 
(32), India (25) and a further 18 countries. See Table I.1 
and Figure I.4. A wide range of manufacturing and services 
sectors is represented in the Scoreboard, including more 
than 50 industries with a special focus on the most 
innovative ones such as the ICT, health, transport and 
engineering related industries. See the number of EU and 
non-EU companies by country in Table I.1, by sector in Table 
I.2 and the top 3 companies by level of R&D investment for 
the main industrial sectors in Table I.3.
0 200 400 600 800 1 000
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BERD
SB2015
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TABLE I.1 - DISTRIBUTION OF COMPANIES BY COUNTRY. 
Note: 2500 companies with R&D investment above €21.1 million.
Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
TABLE I.2 - DISTRIBUTION OF COMPANIES BY INDUSTRIAL SECTOR. 
Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
number of companies by country
EU NON-EU
UK 133 US 837
Germany 132 Japan 356
France 83 China 327
Sweden 40 Taiwan 111
The Netherlands 38 South Korea 75
Denmark 29 Switzerland 58
Italy 29 Canada 32
Ireland 21 India 25
Finland 19 Israel 20
Spain 17 Australia 14
Austria 15 Norway 12
Belgium 14 Brazil 9
Luxembourg 9 Singapore 7
Portugal 4 Turkey 6
Greece 3 Malaysia 4
Slovenia 1 New Zealand 3
Czech Republic 1 Russia 3
Hungary 1 Mexico 2
Malta 1 Further 8 Countries 9
TOTAL 590 TOTAL 1910
number of companies in the 10 most numerous industries
EU NON-EU
Pharmaceuticals & Biotechnology 78 Pharmaceuticals & Biotechnology 291
Industrial Engineering 69  Technology Hardware & Equipment 268
Software & Computer Services 47  Software & Computer Services 231
Electronic & Electrical Equipment 42 Electronic & Electrical Equipment 186
Automobiles & Parts 35 Industrial Engineering 130
Technology Hardware & Equipment 30 Automobiles & Parts 121
Banks 28 Chemicals 104
Chemicals 22 Health Care Equipment & Services 76
Health Care Equipment & Services 22 General industrials 69
Aerospace & Defence 19 Construction & Materials 50
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TABLE I.3 - TOP 3 COMPANIES BY R&D FOR THE MAIN INDUSTRIES INCLUDED IN THE 2016 SCOREBOARD. 
Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Concentration of R&D investment by company, sector and country
Industrial R&D is highly concentrated. A small subset of 
companies, industries and countries accounts for a large 
share of the total R&D investment of the whole sample 
of 2500. For example, the top 100 companies account 
for 53.1% of the R&D, the companies based in the three 
largest countries (US, Japan and Germany) account for 
63.2% and the four largest industries (Pharmaceuticals 
& Biotechnology, Automobiles & Parts, Technology 
Hardware & Equipment, Software & Computer Services) 
account for 61.7% of the total R&D investment. This is 
illustrated in Figures I.2 and I.3.
pharmaceuticals & biotech. Automobiles & Parts Technology Hardware & Equip.
NOVARTIS Switzerland VOLKSWAGEN Germany INTEL US
ROCHE Switzerland TOYOTA MOTOR Japan HUAWEI China
JOHNSON & 
JOHNSON US GENERAL MOTORS US APPLE US
software & computer 
services
electronic & electrical 
equipment Industrial Engineering
ALPHABET US SAMSUNG South Korea CATER PILLAR US
MICROSOFT US SIEMENS Germany VOLVO Sweden
ORACLE US HITACHI Japan CRRC CHINA China
Chemicals Aerospace & Defence General Industrials
BASF Germany AIRBUS The Netherlands GENERAL ELECTRIC US
DUPONT US BOEING US TOSHIBA Japan
DOW CHEMICAL US UNITED TECHNOLOGIES US PHILIPS The Netherlands
Leisure Goods Health Care Equipment & Services Banks
SONY Japan MEDTRONIC Ireland BANCO SANTANDER Spain
PANASONIC Japan BOSTON SCIENTIFIC US BARCLAYS UK
LG ELECTRONICS South Korea THERMO FISHER SCIENTIFIC US DEUTSCHE BANK Germany
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FIGURE I.3 - R&D INVESTMENT OF THE 2015 SCOREBOARD AGGREGATED BY COUNTRY. 
Source: The 2015 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
FIGURE I.2 - COMPANIES OF THE 2016 SCOREBOARD RANKED BY R&D. 
Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE I.4 - DISTRIBUTION OF THE 2500 COMPANIES IN THE 2016 SCOREBOARD BY HEADQUARTERS COUNTRY. 
Note 1: Number of companies indicated besides the country code (includes only countries with at least one company).
Note 2: R&D for countries with more than 10 companies is represented with a bubble whose size is proportional to R&D in 2015/16
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Users of Scoreboard data should take into 
account the methodological limitations 
summarised here, especially when perfor-
ming comparative analyses (a full descrip-
tion of the methodology is found in Annex 2): 
A typical problem arises when comparing 
data from different currency areas. The Sco-
reboard data are nominal and expressed in 
Euros with all foreign currencies converted 
at the exchange rate of the year-end closing 
date (31.12.2015). The variation in the ex-
change rates from the previous year directly 
affects the ranking of companies, favouring 
those based in countries whose currency 
has appreciated with respect to the other 
currencies. In this reporting period, the ex-
change rate of the Euro depreciated by 10 % 
against the US dollar and the Japanese Yen, 
and by 5.8 % against the pound sterling. 
The growth rate of the different indicators 
for companies operating in markets with 
different currencies is affected in a different 
manner. In fact, companies' consolidated 
accounts have to include the benefits and/
or losses due to the appreciation and/or de-
preciation of their investments abroad. The 
result is an 'apparent' rate of growth of the 
given indicator that understates or oversta-
tes the actual rate of change. For example, 
this year the R&D growth rate of companies 
based in the Euro area with R&D invest-
ments in the US is partly overstated because 
the 'benefits' of their overseas investments 
due to the depreciation of the Euro against 
the US dollar (from $1.21 to $1.09). Conver-
sely, the R&D growth rate of US companies 
is partly understated due to the 'losses' of 
their investments in the Euro area. Similar 
effects of understating or overstating figu-
res would happen for other indicators, e.g. 
for net sales. 
When analysing data aggregated by country 
or sector, be aware that in many cases, the 
aggregate indicator depends on the figures 
of just a few firms. This is due, either to the 
country's or sector's small number of firms in 
the Scoreboard or to the indicator dominated 
by a very few large firms.
The different editions of the Scoreboard 
are not directly comparable because of the 
year-on-year change in the composition of 
the sample of companies, i.e. due to newco-
mers and leavers. Every Scoreboard compri-
ses data of several financial years allowing 
analysis of trends for the same sample of 
companies.
In most cases companies' accounts do not 
include information on the place where R&D 
is actually performed; consequently the 
approach taken in the Scoreboard is to attri-
bute each company’s total R&D investment 
to the country in which the company has its 
registered office or shows its main economic 
activity. This should be borne in mind when 
interpreting the Scoreboard's country classi-
fication and analyses.
Growth in R&D can either be organic, the 
outcome of acquisitions or a combination 
of the two. Consequently, mergers and ac-
quisitions may sometimes underlie sudden 
changes in specific companies' R&D or sales 
growth rates and/or positions in the rankings. 
Other important factors to take into account 
include the difference in the various coun-
tries’ (or sectors’) business cycles which may 
have a significant impact on companies' in-
vestment decisions, and the initial adoption 
or stricter application of the International 
Financial Reporting Standards (IFRS)5.
5 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS 
(see: EC Regulation No 1606/2002 of the European Parliament and of the Council of 19 July 2002 on the application of international accoun-
ting standards at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32002R1606:EN:HTML).
Box I.1 -  
Methodological caveats
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Report structure
Chapter 1 presents the worldwide trends of industrial R&D. It provides 
an overview of the main indicators for the top 2500 companies ranked 
by level of R&D investment and the main changes that took place over 
the last year. An analysis of the main indicators of the company data 
aggregated by world regions is included together with the performance 
of companies over the past 10 years.
The performance of individual companies among the top R&D investors 
is provided in Chapter 2. The list of the top 50 and top 100 R&D 
companies is examined highlighting those companies showing 
remarkable R&D and economic results and improvement in their R&D 
ranking over the last 12 years. It also includes an analysis of the ranking 
of large companies by R&D intensity.
Chapter 3 presents an analysis of the main R&D and economic 
indicators of companies aggregated by industrial sector, including 
comparisons of EU companies with their main worldwide counterparts. 
Chapter 4 discusses the trends on R&D and economic performance 
of the companies included in the extended sample comprising the top 
1000 R&D investors based in the EU, focussing on the largest R&D 
countries of the EU accounting for more than 97% of the total R&D of 
the sample of 1000 companies based in the EU.
1
2
3
4
27The 2016 EU Industrial R&D Scoreboard
5
6
7
ANNEXES
Annex 1 provides background and methodological information about 
how the Scoreboard is prepared. The methodological approach of the 
Scoreboard, its scope and the limitations are described in Annex 2. 
The sector and country composition of the EU 1000 sample is found in 
Annex 3. The access to the full dataset is shown in Annex 4. 
The complete data set is freely accessible online at:  
http://iri.jrc.ec.europa.eu/scoreboard16.html
Chapter 5 examines the dynamics of R&D of the Scoreboard companies 
over the last 12 years. The objective is to investigate the patterns and 
persistence of the R&D growth process.
An analysis combining R&D and patent data on the parent companies 
and their subsidiaries is presented in Chapter 6, aimed at improving 
the knowledge about the geographic distribution of R&D activities 
across territorial borders.
Finally, Chapter 7 analyses trends of mergers and acquisitions (M&A) 
activities involving Scoreboard companies over the period 2003-2012. 
The aim is to assess the effects of transferring companies’ ownership and 
control across countries and industries and to characterise strategies of 
acquiror companies and the effects of M&A on company performance.
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1 WORLDWIDE TRENDSIN CORPORATE R&D
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The 2500 companies are grouped into four main sets: 
the top 590 companies based in the EU, 837 companies 
from the US, 356 companies from Japan, 327 compa-
nies based in China and 390 companies from the rest of 
the world (RoW group, comprising companies based in 
Taiwan (111), South Korea (75), Switzerland (58), Cana-
da (32) and a further 19 countries).
R&D investments and economic results of companies in 
2015 show important variations across countries and in-
dustries. Companies in aggregate increased significantly 
their R&D investments while showing an important decli-
ne in revenues. However, the increase of R&D was driven 
by high-tech industries whereas the decrease of sales 
was dominated by low-tech sectors, mainly oil- and mi-
ning-related industries.
As observed in past years, this reflects continued and 
persistent market and economic uncertainties in 2015. 
Box 1.1 below summarises the economic background in 
2015 and early 2016 in which global R&D companies 
have been operating. 
To interpret these results, it is important to remember the 
effects of the exchange rates, especially on rankings and 
growth rates. In this reporting period, the exchange rate 
of the Euro depreciated by 10 % against the US dollar 
and the Japanese Yen, and by 5.8 % against the pound 
sterling. The main effects of this is that companies based 
in the Euro area are penalised in terms of R&D rankings; 
however, in terms of growth rates, their results are overs-
tated due to the revaluation of their foreign R&D and 
sales (see Box I.1).
Key findings
• The top 2500 Scoreboard companies invested in R&D 
€696.0bn in 2015/16, an increase of 6.6% respect 
to 2014/15, a similar growth rate to the year before 
(6.8%). On the contrary, the net sales declined (-3.6%), 
compared with an increase of 2.2% in 2014/15. The 
growth in R&D was driven by companies operating in 
the largest R&D-investing industries (ICT, health and 
auto), that also increased significantly net sales, while 
the overall fall in net sales was mostly due to oil- and 
mining-related companies. 
• The 590 EU companies increased R&D investment at 
higher rate than the world average, at 7.5% (mostly 
due to Auto and High-tech companies) while decrea-
sing net sales by 3.6% (mostly due to oil-related com-
panies). The 837 US companies reported a significant 
increase in R&D (5.9%) but also an important decline 
in net sales (-4.0%). The 356 Japanese companies 
showed a more modest R&D increase (3.3%) while 
net sales remained practically unchanged (0.2%). As 
in the past few years, companies based in China con-
tinued to show the best performance in terms of R&D 
growth (24.7%) but presented also a significant de-
crease in net sales (-6.2%).
• Outside of the EU, the US, Japan and China (the Rest 
of the World group comprising 390 companies), the 
largest increases in R&D investment were reported by 
companies based in Taiwan (7.1%) and South Korea 
(3.7%). The net sales of companies from the RoW 
group decreased in the largest countries (e.g. Switzer-
land -3.3% and South Korea -1.7%).
• Trends over the past 10 years show a worldwide but 
hesitant recovery of companies' net sales following 
the financial crisis. On the contrary, companies' R&D 
growth has been positive all over the world since 
2010. Recovery of R&D growth has been more pro-
nounced for the US and EU companies, the latter 
showing the best performance in the last year.
This chapter provides an overview of the main trends in R&D and economic indicators 
for the world's top 2500 companies (those that invested more than €21 million in 
R&D in 2015/16). It includes the analysis of the long-term performance of companies 
aggregated by main world regions.
Worldwide trends in corporate R&D1
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Box 1.1 -  
Economic environment for the 
Scoreboard companies in 2015/16.
From mid-2015 companies and investors 
were watching the US central bank (the Fed) 
closely to see when it would start raising in-
terest rates to more normal levels from the 
near zero they had remained at since the fi-
nancial crisis. The first rate rise for nearly 10 
years eventually came in December 2015 
when rates moved from zero to 0.25%. The 
Fed indicated that it expected the US eco-
nomy to be strong enough to enable it to 
make four more rate rises during 2016. The 
Bank of England was expected to follow the 
Fed since UK growth was also strong. The US 
and UK were expected to raise rates first sin-
ce their World Bank GDP growth rates in 2015 
at 2.4% and 2.3% respectively were higher 
than other major developed economies such 
as the Eurozone (1.7%) and Japan (0.5%). 
The growth rate of the second largest eco-
nomy – China - has also been dropping sha-
rply from 12% in early 2010 to about 6.7% 
in early 2016 and this has contributed to the 
lower world growth rate.
However, US/UK rate rises were not what ha-
ppened in 2016. Up to the end of November 
2016, the US had still not raised rates at all 
during 2016 and the uncertainty ushered in 
by the Brexit vote in June 2016 led to the 
Bank of England reducing rates to 0.25% 
and restarting quantitative easing (QE). The 
low growth outlook in the Eurozone with high 
unemployment in many Eurozone countries 
led to the ECB cutting rates to 0% (with the 
overnight deposit rate negative) and increa-
sing QE in March 2016.  The Bank of Japan 
found it ever harder to find bonds to purchase 
in its efforts to fight deflation and implemen-
ted a negative interest rate of -0.1% in Fe-
bruary 2016. This all meant that the interest 
rate environment remained low throughout 
2015/16 with negative rates in the Eurozo-
ne, Denmark, Sweden, Switzerland and Japan 
in 2016. According to Bloomberg, by June 
2016 about $10 trillion of government bonds 
worldwide (mainly Japan and Europe) offered 
yields below zero. In summary, despite central 
bank actions, developed economies have a 
current combination of low interest rates, low 
growth and low inflation so concerns remain 
about how to ensure that deflation is avoided.
Companies have adjusted to this low interest 
rate environment with recent debt from large 
multinationals in stable sectors (e.g. Sanofi, 
Unilever) issued as  zero coupon securities 
and short-term paper sold by General Electric 
and Johnson & Johnson now trading below 
zero in the secondary market. Some compa-
nies have used the current low interest rates 
to grow their earnings per share (eps) even 
though their revenue is growing slowly or 
not at all. They have done this by increasing 
borrowings either to make share buybacks 
(which increase earnings per share though 
not earnings) or to take on debt to fund lar-
ge acquisitions (which increase eps by adding 
to earnings but not to the number of shares). 
This contrasts with many companies in the 
Scoreboard which invest in R&D for new and 
improved products to drive increases in reve-
nue, profits and eps. This is particularly true for 
companies with global positions in growing 
markets (see Alphabet, Gilead and Facebook 
in the Scoreboard’s top 50 for example).
Another major influence on company perfor-
mance in 2015/16 has been the continuing 
low level of oil and commodity prices. The oil 
price fell below $50 in January 2015 and re-
mained in the $40-50 range up to late 2016 
with the exception of excursions to $60 in 
spring 2015 and to around $30 in early 2016. 
The prices of commodities such as iron ore 
have also fallen and remained low as de-
mand from China reduced. These trends have 
reduced the sales of oil and mining compa-
nies and of the wide range of companies 
supplying these industries and are evident in 
the Scoreboard sales and profitability figures 
for companies in these sectors.
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1.1 | Indicator changes over the last year
The main economic and financial indicators for the year 
2015 for the set of 2500 companies are summarised in 
Table 1.1.
• Overall R&D investment continued to increase in 
2015/16 for the fifth consecutive year. The 2500 
Scoreboard companies invested €696.0 billion in R&D, 
6.6% more than in 2014/15, following an increase 
of 6.8% in the year before. Seventy per cent of the 
companies showed positive R&D growth in 2015/16. 
• For the fourth consecutive year, the net sales of the 
2500 companies underperformed with respect to 
R&D, decreasing by 3.6%, compared with an increase 
of 2.2% over the previous period. Operating profits of 
the companies also decreased significantly compared 
with the previous year, although a large proportion 
(79%) of companies made profits, similar to the 
proportion of companies (80%) that made profits in 
the previous period.
• Company investments in fixed capital decreased 
slightly by 0.8%, compared with last year's stagnation. 
Capital expenditure as a percentage of net sales, at 
7.1% remained practically the same as that of the 
previous year.
• The number of employees of the 2500 companies in 
the slightly increased (by 1.3%), compared with an 
increase of 1.5 % in 2014/15. 
TABLE 1.1 - OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2016 SCOREBOARD. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor top 100 r&d investors world 2500
R&D in 2015, € bn 369.4 696.0
One-year change, % 6.9 6.6
CAGR 3yr, % 6.4 6.3
Net Sales, € bn 5 512.1 17 686.8
One-year change, % 2.6 -3.6
CAGR 3yr, % 3.0 0.3
R&D intensity, % 6.7 3.8
Operating profits, € bn 629.4 1 517.7
One-year change, % 4.0 -12.3
Profitability, % 11.8 8.7
Capex, € bn 362.7 1 127.5
One-year change, % 6.3 -0.8
Capex / net sales, % 7.1 7.1
Employees, million 11.8 47.4
One-year change, % 2.5 1.3
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1.2 | R&D trends by world region
This section analyses the overall R&D and economic 
performance of the Scoreboard companies according to 
the location of their registered offices in the main world 
regions. The 2500 companies are grouped into four main 
sets: the top 590 companies from the EU, 837 companies 
from the US, 356 from Japan, 327 from China and 390 
from others contries (RoW). The RoW group includes 
companies from China (327), Taiwan (111), South Korea 
(75), Switzerland (58) and companies based in a further 
20 countries.
Figure 1.1 (page 35) and table 1.2 (page 36) summarise 
the companies' indicators aggregated by main world 
region. Table 1.3 shows the main indicators for countries 
included in the RoW group and Table 1.4 presents the 
main indicators for the 4 largest R&D countries of the EU.
Overall trends in the EU
The R&D investment of the top 590 companies based 
in the EU substantially increased in 2015/16, by 7.5%, 
compared with 3.2% in 2014/15. On the other hand, the 
net sales of these EU companies decreased by 3.6%, more 
than the slight 0.7% decline shown in 2014/15.
The companies based in Germany, accounting 
respectively for 37.6% and 30.0% of the EU’s total 
R&D and net sales, made the largest contribution to 
the performance of the EU-590 group. The 132 German 
companies increased R&D by 10.6% and net sales by 
8.7%. These results reflect to a large extent the results 
in the Automobiles & Parts and also good performance 
in ICT and health related sectors. The Automobiles & 
Parts sector, accounting for 53% of R&D and 36% of 
net sales of the group of German companies increased 
R&D by 9.6% and net sales by 15.2%, e.g. double 
digit R&D growth was shown by Daimler, BMW and ZF. 
German companies showed also good performance in 
other sectors, namely double-digit R&D and net sales 
growth in health and ICT-related industries. In particular, 
outstanding double-digit R&D growth was shown by the 
largest German Pharmaceutical companies Bayer and 
Boehringer Sohn. (see further details in Chapter 4 where 
an extended sample of the top 1000 EU R&D investors 
is analysed). 
The other two largest member states of the EU showed 
a mixed performance. Companies based in the UK 
increased R&D by 4.1% but decreased sales significantly 
by 22% (The UK's sales decrease was mostly due to the 
decline in Oil and Mining companies, -37% and -26% 
respectively). Companies based in France increased 
R&D modestly by 2.0% and decreased net sales by 
3.4%. 
Companies based in Ireland made an important 
contribution to the R&D of the EU group increasing R&D 
by 29.6%, though, most of the R&D increase comes 
from a few American health-related companies with 
headquarters in Ireland that made acquisitions during 
2015/16.
Other world regions
The group of US companies increased R&D investment by 
5.9% and decreased sales by 4.0%. The R&D results of 
the US companies mainly reflect the good performance 
of companies from the Pharmaceuticals & Biotechnology 
(13.3%) and Software & Computer Services (11.5%) and 
the fall of net sales is mostly due to oil-related sectors but 
also due to poor sales in sectors such as Industrial Engi-
neering and Automobiles.
Japanese companies underperformed EU and US firms in 
terms of R&D (up by 3.3%) but showed better results in 
terms of net sales growth (+0.2%) mainly because there 
are no sizeable Japanese oil companies. As in the case 
of German companies, the average performance of Japa-
nese companies is strongly dependent on the results of 
the Automobiles & Parts sector (accounting for 29.4% and 
27.1% of the Japanese R&D and net sales respectively). 
This sector showed an increase of 5.5% in R&D and 6.5% 
in net sales in 2015.
Companies based in China reported again the largest 
increase in R&D investment (up by 24.7%) but also 
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showing a significant decrease in net sales (-6.2%). In the 
Chinese group of companies, outstanding performance 
was shown by ICT-related companies Huawei, ZTE and 
Baidu that grew R&D by more than 30% and also net sales 
by more than 20%.
Companies based outside of the EU, US, Japan and China 
(the RoW group) showed a modest R&D investment 
growth (2.4%) and a significant decrease in net sales 
(-4.8%). Companies in the RoW group that showed the 
largest increase in R&D are those based in Taiwan (up by 
7.1%). The companies based in Switzerland, the largest 
R&D investor in this group showed decreases in R&D and 
net sales of 1.5% and 3.3% respectively (with Novartis’s 
divestments contributing significantly to this).
Compared with last year’s Scoreboard, the EU companwies’ 
share of global R&D investment decreased by 1.0 
percentage point (from 28.1% to 27.1%), mostly due 
to the depreciation of the Euro with respect to the main 
currencies (see exchange rates applied in Table A3.1 in 
Annex 2). The R&D share of Japanese companies remained 
FIGURE 1.1 - R&D INVESTMENT BY THE TOP 2500 COMPANIES, BY MAIN WORLD REGION (% OF TOTAL €696.0BN) 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
practically unchanged and that of the US increased by 0.5 
percentage points. The Chinese companies showed the 
largest increase in R&D share, from 5.9% to 7.2%.
The average R&D intensity of the sets of companies based 
in the EU, the US and China increased due to the higher 
growth of R&D investments compared with the growth 
rate of net sales. For the second consecutive year, the 
R&D intensity for companies based in Japan remained 
practically unchanged. 
In 2015/16, average company capital expenditure 
decreased for the third consecutive year for EU companies 
(-1.2%), US companies (-3.0%) and Chinese companies 
(-11.1%). Companies based in Japan increased capex 
significantly by 6.1%.
The average operating profits of companies decreased 
in 2015/16 for most of the groups of companies (EU 
-21.2%; US -7.6% and China -15.8%), except for Japan 
(5.8%). 
SPAIN 0.7%
SWEDEN 1.4%
IRELAND 1.3% 
ITALY 1.7%
THE NETHERLANDS 2.0%
UK 4.1%
FRANCE 4.1%
GERMANY 10.0%
OTHER RoW 3.1%
EU
OTHER EU 1.7%
NUMBER OF
COMPANIES
590
837
356
390
327
Rest of World 
12.8%
Japan 
14.4%
China 
7.2%
US 
38.6%
27.0%
SWITZERLAND 4.0%
SOUTH KOREA 3.7%
TAIWAN 2.0%
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TABLE 1.2 - OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2016 SCOREBOARD. 
Note : The RoW group comprises companies based in Taiwan, South Korea, Switzerland, Canada and a further 19 countries.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor eu usa japan china RoW
No. of companies 590 837 356 327 390
R&D in 2015/2016, € bn 188.3 268.6 99.9 49.8 89.4
World R&D share, % 27.0 38.6 14.4 7.2 12.8
One year change, % 7.5 5.9 3.3 24.7 2.4
CAGR 3yr, % 4.5 6.5 3.9 20.5 6.4
Net Sales, € bn 5 678.4 4 518.8 2 859.6 1 978.9 2 651.2
One year change, % -3.6 -4.0 0.3 -6.2 -4.8
CAGR 3yr, % -2.5 -0.1 5.8 3.1 -0.1
R&D intensity, % 3.2 5.8 3.3 2.5 3.3
Operating Profit, € bn 376.5 581.5 183.0 120.4 256.2
One year change, % -21.2 -7.6 5.8 -15.8 -16.5
Profitability (1) 6.8 12.9 6.8 6.1 9.7
Capex, € bn 317.2 293.8 169.3 124.2 223.1
One year change, % -1.2 -3.0 6.1 -11.1 4.5
Capex intensity, % 6.8 6.6 6.4 6.7 9.7
Employees, million 17.3 11.3 7.4 7.5 3.9
One year change, % 1.0 1.0 1.0 2.9 0.7
The profitability (operating profits as percentage of net 
sales) changed according to the difference between the 
growth rate of sales and profits. Consequently, the avera-
ge profitability decreased for EU companies (from 8.3% to 
6.8%), US companies (from 13.5% to 12.9%) and Chinese 
companies (from 6.8% to 6.1%). And for Japanese compa-
nies the profitability increased slightly from 6.5% to 6.8%.
The sales/employee figure for the EU at €328k is signifi-
cantly lower than that for the US (€400k) or Japan (€386k). 
This is somewhat surprising given the number of oil and mi-
ning companies included in the EU set of companies but re-
flects differences in sector mix between world regions com-
bined with exchange rate effects. In particular, EU sales per 
employee are lowered vs. the US by the EU’s much smaller 
set of high R&D intensity companies but raised by the EU’s 
much larger number of low R&D intensity companies such 
as oil companies that have high sales per employee.
As underlined in previous Scoreboard reports, most of the 
differences in R&D intensity and profitability between re-
gions and countries are related to differences in sector mix. 
The US is by far the strongest region in the group of high 
R&D intensity sectors including pharmaceuticals, health, 
software, and technology hardware whereas the EU and 
Japan are stronger in medium R&D intensity sectors such 
as the automotive and industrial engineering sectors (see 
chapter 3).
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TABLE 1.3 - PERFORMANCE OF COMPANIES BASED IN THE LARGEST COUNTRIES OF THE ROW GROUP. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
TABLE 1.4 - PERFORMANCE OF COMPANIES BASED IN THE LARGEST R&D COUNTRIES OF THE EU. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor switzerland south korea taiwan canada
No. of companies 58 75 111 32
R&D in 2015/2016, € bn 28.0 25.4 14.0 4.7
World R&D share, % 4.0 3.7 2.0 0.7
One year change, % -1.5 3.7 7.1 -2.3
CAGR 3yr, % 2.5 10.4 8.8 -1.0
Net Sales, € bn 377.6 822.5 511.9 115.1
One year change, % -3.3 -1.7 -0.3 1.7
CAGR 3yr, % -0.2 0.8 1.7 4.7
R&D intensity, % 7.4 3.1 2.7 4.1
Operating Profit, € bn 54.4 62.2 35.0 19.1
One year change, % -10.1 18.7 5.4 -16.9
Profitability, % 14.4 7.6 6.8 16.6
Employees, million 1.3 N.A 0.6 0.2
One year change, % 1.2 -2.5 17.2
Factor germany uk france the netherlands
No. of companies 132 133 83 38
R&D in 2015/2016, € bn 69.8 28.2 28.5 14.1
World R&D share, % 10.0 4.1 4.1 2.0
One year change, % 10.6 4.1 2.0 4.1
CAGR 3yr, % 7.5 3.1 0.0 0.7
Net Sales, € bn 1 714.1 1 069.3 1 015.9 368.5
One year change, % 8.7 -22.0 -3.4 1.1
CAGR 3yr, % 2.8 -10.0 -3.0 -0.7
R&D intensity, % 3.9 2.5 2.8 3.8
Operating Profit, € bn 85.2 80.5 63.0 38.4
One year change, % -21.7 -36.8 -20.5 11.4
Profitability, % 5.2 7.6 6.5 10.4
Employees, million 5.6 2.8 3.0 1.2
One year change, % 4.4 0.4 -1.4 1.5
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1.2.1 | Long-term performance of companies by world region
The annual growth rates of R&D investment and net sa-
les and the profitability of companies based in the EU, 
the US and Japan is provided respectively in figures 1.2, 
1.3 and 1.4 for the period 2006-2015. These figures are 
based on our history database comprising R&D and eco-
nomic indicators over the 10 years period 2006-20156 
period (EU 377, US 544 and Japan 311).
The trends observed in these figures show the behaviour 
of these companies including the effects of the crisis that 
began in 2008. The following points are observed:
• Companies based in the EU reversed the negative 
trends of the last three years, showing a modest re-
covery of R&D investment but the losses in net sa-
les observed in the previous period increased further 
(driven by low oil and commodity prices). The profi-
tability of the EU companies decreased over the last 
year and remained substantially lower than that of 
the US companies. 
• The US companies continued to show significant R&D 
investment growth, similar to the level prior to the 
crisis and show a further fall in in net sales growth, 
but well below the level of R&D growth. The US-ba-
sed companies continued to show a very high level 
of profitability characteristic of the well-represented 
R&D-intensive sectors that has been stable since re-
covery from the crisis in 2010. The profitability of the 
US companies is higher than their EU counterparts 
and especially higher than the Japanese ones.
• Japanese companies, hit hard by the crisis in 
2008-2009 and by the earthquake and tsunami in 
2011, continued the recovery, in R&D with positive 
growth in net sales, observed in the past period 
but at a more moderate pace. The profitability of 
Japanese companies also continued to recover 
in 2015/16 but remained at relatively low levels 
comparable to the EU but well below that of the 
US companies. 
6 The profitability in Figures 1.1, 1.2 and 1.3 refer to the ratio of operating profits over net sales.
FIGURE 1.2 - ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE EU COMPANIES.
Note: * Figures for 2015 for the whole sample of 590 EU companies were 7.5% for R&D, -3.6 for net sales and 6.6% profitability. 
The figure is for 377 out of the 2500 companies for which R&D and net sales are available for the full 10 years period.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 1.3 - ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE US COMPANIES.
Note: * Figures for 2015 for the whole sample of 837 US companies were 5.9% for R&D, -4.0 for net sales and -7.6% profitability. 
The figure is for 544 out of the 2500 companies for which R&D and net sales are available for the full 10 years period.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
FIGURE 1.4 - ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE JAPANESE COMPANIES.
Note: * Figures for 2015 for the whole sample of 356 Japanese companies were 3.3% for R&D, 0.2 for net sales and 6.8% profitability. The 
figure is for 311 out of the 2500 companies for which R&D and net sales are available for the full 10 years period.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
1.2.2 | R&D trends by world regions and sector groups over the last 10 years 
Trends in R&D over the long-term are presented in figure 
1.5 for the main world regions. The figures refer to a set of 
companies that reported R&D over the whole 10 years pe-
riod 2006-2015 (EU-456, US-614, Japan-343 and other 
countries-420). The R&D data are broken down into groups 
of industrial sectors, each with a characteristic range of 
R&D intensities (see definition in Box 1.1)
The following points can be observed regarding the overall 
R&D changes in the period 2006-2015 (figure 1.6):
• Worldwide, companies increased R&D by 59.1% (EU by 
52.7 %; US by 65.0% and Japan by 12.5%) over the 
ten years.
• For the 456 EU companies, the largest percentage 
R&D increases were in low R&D-intensive sectors 
(65.2%) and medium-high sectors (56.5%). 
• For the 614 US companies, the largest percentage 
R&D increases were in high R&D-intensive sectors 
(78.1%) and medium-low sectors (70.8%). 
• For the 343 Japanese companies, the largest percen-
tage R&D increases were in medium-high R&D-inten-
sive sectors (19.5%) and medium-low sectors (3.8%).
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*This classification takes into account the R&D intensity of all companies aggregated by ICB 3-digits 
sectors: High above 5%; Medium-high between 2% and 5%; Medium-low between 1% and 2% and Low 
below 1%. Some sectors are adjusted to compensate the insufficient representativeness of the Scoreboard 
in those sectors using the OECD definition of technology intensity for manufacturing sectors7.
7 ISIC REV 3. Technology intensity definition, OECD, 7 July, 2011.
Box 1.2 -  
Grouping of industrial sectors according 
to R&D intensity (R&D as % of net sales)*
FIGURE 1.5 - R&D INVESTMENT TRENDS BY THE SCOREBOARD COMPANIES FOR MAIN WORLD REGIONS.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
High R&D intensity sectors include mainly 
Pharmaceuticals & biotechnology; Health 
care equipment & services; Technology 
hardware & equipment; Software & 
computer services, Aerospace & defence 
and Leisure Goods.
Medium-high R&D intensity sectors 
include mainly Electronics & electrical 
equipment; Automobiles & parts; Industrial 
engineering; Chemicals; Personal goods; 
Household goods; General industrials; 
Support services.
Medium-low R&D intensity sectors include 
mainly Food producers; Beverages; Travel 
& leisure; Media; Oil equipment; Electricity; 
Fixed line telecommunications.
Low R&D intensity sectors include mainly 
Oil & gas producers; Industrial metals; 
Construction & materials; Food & drug 
retailers; Transportation; Mining; Tobacco; 
Multi-utilities.
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1.2.3 | Employment trends by regions and sector groups
Among the 2500 companies in this year's Scoreboard, 
2031 companies reported number of employees. In to-
tal these companies employed 47.4 million people in 
2015, 1.3% more than the previous year. 
The distribution of employees by region was 17.3 mi-
llion for companies based in the EU, 11. 3 million for US 
companies, 7.4 million for the Japanese companies, 7.5 
million for the Chinese companies and 3.9 million for the 
rest of countries.
Trends on employment over the long-term are presen-
ted in figure 1.6 for the main world regions. The figures 
refer to a set of companies that reported number of 
employees over the whole 10 year period 2006-2015 
(EU-393, US-515, Japan-303 and other countries-290) 
and are broken down into groups of industrial sectors 
with characteristic R&D intensities (see definition in 
Box 1.2). 
The following points can be observed regarding the 
changes in number of employees in the period 2006-
2015 (figure 1.6): 
• Overall worldwide employment increased by 23.9% 
from 2006 to 2015 led by increases in high R&D-
intensive sectors (32.1%) and medium-high sectors 
(31.2%).
• For the EU companies, the overall employment 
growth was 17.1 %, increasing by 40.3% in high 
R&D-intensive sectors, by 28.4% in medium-high 
and by 0.3 % in low sectors.
• For the US companies, the overall employment grow-
th (17.9%) greatly varies by sector group: a strong 
increase for high R&D-intensive sectors (25.8%) 
and a sharp decrease in low sectors (-23.6%).
• For the Japanese companies, the overall employ-
ment increase of 21.2% corresponded to an increa-
se of 41.0% in medium-low R&D-intensive sectors 
and of 25.6% in medium-high sectors.
• The ratio of employment in high to medium-high 
R&D intensity sectors for companies based in Japan 
fell from 33.2% to 27.3%, rose for EU companies, 
from 38.8% to 42.4%, and significantly increased 
for US companies from 90.0% to 97.3%. 
It is important to remember that data reported by the Sco-
reboard companies do not inform about the actual geogra-
phic distribution of the number of employees. A detailed 
geographic analysis should take into account the location 
of subsidiaries of the parent Scoreboard companies (see for 
example in the 2015 Scoreboard report, an analysis of the 
location of companies' economic and innovation activities).
FIGURE 1.6 - EMPLOYMENT TRENDS BY THE SCOREBOARD COMPANIES FOR MAIN WORLD REGIONS. 
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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2 TOP R&D INVESTING COMPANIES
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This chapter describes the performance of individual 
companies, with a focus on the results of top R&D investors, 
highlighting those companies that show considerable 
changes in economic performance, in particular from 
an R&D viewpoint. Due to data availability, R&D figures 
for some companies may be under- or over-stated (see 
explanations in Box 2.1).
The world's top 100 R&D companies account for 53.1% 
of the R&D of the whole set of 2500 and are analysed, 
highlighting those presenting important changes from the 
previous year and those showing the best performance in 
terms of R&D and economic growth over the last 10 years. 
The group of top R&D investors includes major industrial 
players in key sectors such as IT hardware & software, 
pharmaceuticals and automobiles & parts. Key technological 
and market trends explain to a large extent changes 
observed in the Scoreboard indicators for these companies. 
Examples of such developments are illustrated in Box 2.2
The R&D ranking of the top 50 companies is presented 
in figure 2.1 and table 2.1 shows changes in such ranking 
since the first Scoreboard in 2004. A ranking of the top 
R&D investors by R&D intensity is shown in Table 2.2, 
indicating the reasons for main changes observed over the 
last period. 
Key findings
• For the third consecutive year, the two top R&D in-
vestors remain the same: Volkswagen from Germany 
in the 1st place and Samsung Electronics from South 
Korea in the 2nd position.
The other companies in the top-ten are Intel, Alpha-
bet (previously Google), Microsoft and Johnson & Jo-
hnson from the US; Novartis and Roche from Swit-
zerland; Huawei from China and Toyota Motor from 
Japan.
• The top 100 companies, accounting for 53.1% of 
the total R&D performed by all the 2500 compa-
nies, showed growth of R&D and net sales (6.9% and 
2.5%) above the world average. Of these 100 compa-
nies, 68 increased R&D investment (vs. 71 in 2014), 
including 33 companies with double-digit R&D growth 
and 32 companies that decreased R&D. Regarding 
net sales, 61 companies reported an increase (vs. 71 
in 2014), including 29 companies with double-digit 
sales growth.
• The top 100 group includes:
 ◦ 30 EU companies of which 23 have increased 
R&D (17 by more than 10%), 
 ◦ 35 US companies of which 20 increased R&D 
(8 by more than 10%), 
 ◦ 16 from Japan of which 8 increased R&D (2 by 
more than 10%) and 
 ◦ 19 companies from the RoW group of which 14 
increased R&D (7 by more than 10%).
• The 5 companies showing the largest increase in R&D 
are Allergan, Ireland (146.6% due to acquisition); CRRC 
China (92.0%); Facebook, US (80.6%); Celgene, US 
(60.7%) and Telecom Italia (53.8%). The companies 
with the largest decrease in R&D are Fujitsu, Japan 
(-11.3%); Novartis, Switzerland (-9.5%, partly due to 
divestments); Takeda Pharmaceutical (-9.5%); Petro-
china (-9.4%) and NTT, Japan (-8.7%).
Top R&D Investing Companies2
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2.1 | General trends
In the 2016 Scoreboard 136 companies have an R&D in-
vestment of more than € 1.0bn (42 from the EU and 45 
from the US) while 61 have R&D exceeding € 2.0bn (20 
from the EU and 25 from the US). 
The top 10 companies invested more than € 5.0bn in R&D 
and account for 14.8 % of the total R&D investment by the 
2500 Scoreboard companies.
The two top R&D investors are the same as in last 
year's Scoreboard: In the 1st place the German company 
Volkswagen (€13.6bn) and in the 2nd position from South 
Korea Samsung Electronics (€12.5bn). The other companies 
in the top-ten are Intel, Alphabet and Microsoft (€11bn) from 
the US; Novartis (€9.0bn) and Roche (€8.6bn) from 
Switzerland; Huawei (€8.4bn) from China; Johnson & 
Johnson (€8.3bn) from the US and Toyota Motor (€8.0bn) 
from Japan.
The top 100 companies invested €369.4bn, accounting for 
53.1% of the total R&D investment and 30.0% of the total 
net sales by all the 2500 Scoreboard companies. The EU 
has 30 companies among the top 100 R&D investors, one 
company more than it had in the 2015 Scoreboard, howe-
ver, two of these companies (Allergan and Medtronic) are 
US companies with operational headquarters in the US but 
registered offices in Ireland.
The US has 35 companies, two less than it had last year and 
Japan has 16, same number than in last year’s Scoreboard.
The EU companies in the top 100 are mainly from the Au-
tomobiles & Parts (8), Pharmaceuticals & Biotechnology 
(8), ICT sectors (4) and Aerospace & Defence (2). The US 
companies are mainly from the ICT (13), Pharmaceuticals & 
Biotechnology (10), and Chemicals (3) sectors. The Japane-
se companies operate mainly in the Automobiles & Parts (4) 
and Pharmaceuticals (4) sectors.
Sixty-eight companies in the top 100 have shown positive 
R&D investment growth. Among them, 33 companies had 
double-digit R&D growth, and of these, 21 companies also 
showed double-digit growth in net sales. 
Most of the top 100 companies showing double-digit R&D 
increases are in the Pharmaceuticals & Biotechnology (7), 
ICT (5) and Automobiles & Parts (5) sectors. The 5 com-
panies showing the largest increase in R&D are Allergan, 
Ireland (146.6% due to acquisition); CRRC China (92.0%); 
Facebook, US (80.6%); Celgene, US (60.7%) and Telecom 
Italia (53.8%).
As mentioned above, 21 companies had double-digit grow-
th in R&D and net sales, the top 5 companies among them 
are Facebook, Medtronic, Huawei, Baidu and Apple.
Amongst the top 100 companies only four made losses 
(Allergan, Bombardier, Toshiba and Volkswagen) with 12 
showing profitability of only 5% or less but 24 showing pro-
fitability of over 20%. All but two of the 24 were from the 
very high R&D intensity sectors of biopharma, software and 
technology hardware; the other two were Procter & Gamble 
and Monsanto. There are currently no profitability data for 
four of the top 100. 
Thirty-two companies in the top 100 have experienced a 
decrease in R&D investment. The companies with the lar-
gest decrease in R&D are Fujitsu, Japan (-11.3%); Novar-
tis, Switzerland (-9.5%); Takeda Pharmaceutical (-9.5%); 
Petrochina (-9.4%) and NTT, Japan (-8.7%).
The R&D intensity of companies in the top 100 (6.8%) in-
creased, as in the previous year, due to R&D growth (6.9%) 
being higher than net sales growth (2.5%). The EU compa-
nies in the top 100 have the same R&D intensity as that of 
non-EU companies (6.7%).
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The Scoreboard relies on consistent dis-
closure of R&D investment in published 
annual reports and accounts. However, due 
to different national accounting standards 
and disclosure practices, in some cases, 
R&D costs cannot be identified separately 
in companies' accounts, e.g. appearing inte-
grated with other operational expenditures 
such as engineering costs. To avoid overs-
tatement of R&D figures, the Scoreboard 
methodology excludes R&D figures that are 
not disclosed separately (see methodologi-
cal notes in Annex 2). Inevitably, the strict 
application of this criterion may lead to un-
derstating the actual R&D effort of some 
companies. 
An example of a possible large understate-
ment of R&D figures is the US company Ama-
zon. This company reported a combined figure 
of $12.54bn for ‘R&D and content’ invest-
ment in its latest annual report together with 
capitalised R&D of $642m which, following 
the methodology, is the figure mentioned in 
the Scoreboard. With this R&D figure, Amazon 
appears in position 215th in the R&D ranking 
whereas according to its large overall 'innova-
tion' investment it should be in a much higher 
position in the R&D ranking (Amazon also re-
ported a 35% increase in R&D and content 
from last year). For example, the best esti-
mate from the information available of Ama-
zon’s R&D is in the range of €8bn and this 
would place the company at #11 or higher in 
the top 50 (below Toyota but above Apple). 
There are two main types of technologi-
cal advance. Sustaining technological 
innovations that bring better products 
and services to an established market and 
can provide opportunities for companies 
to improve their competitive positions and 
disruptive technological innovations 
which bring to market completely new pro-
ducts and services. These disruptive techno-
logies may well be developed by companies 
new to a sector as well as innovative com-
panies within a sector. New entrant compa-
nies with disruptive technologies can grow 
quickly and even supplant the established 
leading companies. A classic example of 
this is the way in which the advent of di-
gital photography led to Kodak, the global 
market leader in film photography, filing for 
bankruptcy in 2012.Examples of important 
current sustaining technological inno-
vations are:
• Monoclonal antibodies which are 
now the basis of an increasing range 
of modern drugs. Many pharmaceutical 
companies have partnered with biotech 
companies such as MorphoSys and Re-
generon to access new antibodies and 
hence bolster their clinical pipelines.
• Low power, high performance chip 
designs by ARM now dominate smar-
tphones and other mobile devices and 
are likely to be very important for the IoT 
(internet-of-things). ARM kept improving 
its designs and thus built up a share of 
over 95% of the global smartphone 
market from its origins as a supplier for 
early simple mobile phones. This was 
achieved despite Intel’s dominant posi-
tion in chips for PCs and servers.
Box 2.1 -  
Understatement or  
overstatement of R&D figures
Box 2.2 -  
Key technological trends affecting 
the top R&D investing companies
44 The 2016 EU Industrial R&D Scoreboard
• Standard sustaining technologies 
for individual companies include new 
model ranges from car makers, new 
generation smartphones (Samsung S7 
Edge, Apple iPhone 7), improved IT appli-
cations in healthcare (Cerner and Cra-
neware), improved drugs (e.g. Gilead’s 
improved antivirals for HIV and Hepatitis 
C) and higher performance semiconduc-
tor chips enabled by each new genera-
tion of precision lithography systems 
(from ASML).
But disruptive technological innova-
tions tend to have much greater effects 
on existing markets and companies. The 
technologies underlying the most likely me-
dium-term disruptions are drawn from ICT 
[e.g. big data, AI (artificial intelligence), IoT], 
biotechnology [low cost genomic sequen-
cing, gene editing, immunotherapy, stem 
cells], new materials [nanotechnology, gra-
phene, biomaterials] and systems [robotics, 
self-driving cars, renewable energy]. A recent 
example of disruption is the way online ad-
vertising has grown rapidly to the point that 
it is predicted by eMarketer to overtake TV 
advertising for the first time in 2016. And it is 
dominated by just two relatively new compa-
nies - Google and Facebook - with 64% of the 
large US market. Examples of other potential 
areas for disruption are:
• Transport industry. Both self-dri-
ving technology and zero emissions 
electric cars may well disrupt the au-
tomotive industry while Uber is disrup-
ting the taxi business. Tesla, a new com-
pany, has tripled its R&D in the last two 
years, sells the best performing electric 
car on the market in terms of range and 
acceleration and is building a giga-fac-
tory for substantially lower cost lithium 
batteries. Then there are self-driving car 
developments led by Alphabet and Tes-
la, some in association with conventional 
automotive companies. Tesla announ-
ced that all its production vehicles will 
be equipped with the hardware for full 
self-driving capability with features for 
full autonomy predicted to be activa-
ted by end 2017. The 2016 Paris Motor 
Show demonstrated that existing auto-
motive companies are now responding 
to these developments with Daimler and 
Volkswagen both demonstrating electric 
concept cars – the EQ and ID respectively. 
Both companies plan to have full ranges 
of many electric models on the market 
by 2025. And Daimler is setting up a new 
digital division to develop connected and 
autonomous cars. Robotic ships are now 
possible although they will initially be led 
in convoys by a manned lead ship. Robo-
tic aircraft in the form of armed military 
drones are already in service and there 
are proposals to use smaller drones for 
parcel deliveries.
• Both medicine and agriculture (ge-
netically modified plants and farm ani-
mals) look set to be profoundly influenced 
by gene editing (insertion, deletion or re-
placement of DNA at a specific site in the 
genome of an organism or cell using the 
latest CRISPR/Cas9 technique). For exam-
ple, the successful gene editing treatment 
of a one-year old girl with leukaemia was 
reported in November 2015. Then Genus 
(UK) reported in December 2015 that it 
had used gene editing to develop pigs 
resistant to porcine reproductive & respi-
ratory syndrome virus, a disease that can 
be fatal. Gene editing to treat inherited di-
seases is one example of personalised 
medicine. Lower cost next generation 
genomic sequencing, e.g. from Illumina 
(US) and probably Oxford Nanopore (UK) 
will be important in determining whether 
a person is at risk of a particular disease 
and then informing personal treatment 
decisions. Gene editing holds the promise 
of curing many inherited diseases.
• Medicine is a field where there are many 
potential disruptions with stem cells 
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being an important example. They have 
been used for bone marrow transplants 
(to treat leukaemia) but early work su-
ggests their use might be expanded to 
treat a range of serious diseases such 
as heart disease, cancer, type 1 diabetes 
and retinal diseases. Success with these 
applications could well disrupt compa-
nies providing the current treatments for 
these diseases.
• Other health sector technological 
trends. Technological developments 
are likely to change many other aspects 
of the health sector with robot-assis-
ted surgery developing fast (Intuitive 
Surgical’s da Vinci system from the US 
is the market leader) and likely to re-
quire less and less human intervention 
in the future. Then there are more and 
more health diagnostic and elec-
tronic products being launched such 
as the world’s smallest pacemaker 
that can be implanted inside the heart 
through the femoral vein (launched by 
Medtronic in 2016). And cures are on 
the horizon for some of the most se-
rious diseases. These include immu-
notherapy which enables the body’s 
immune system to attack a growing 
range of cancers (AstraZeneca, Bris-
tol-Myers Squibb, Merck and Roche). 
Then there is progress with treatments 
for some of the most serious neurolo-
gical diseases where late stage clinical 
trials are showing promise for Alzhei-
mer’s (Biogen and Eli Lilly) with other 
trials for Parkinson’s (Prothena and 
Roche). Last but not least collabora-
tions between ICT and health compa-
nies and institutes are starting with 
medical big data analytics exemplified 
by the partnership between Alphabet’s 
Verily Life Sciences and GlaxoSmithKli-
ne. This partnership is called Galvani 
Life Sciences and aims to treat a wide 
range of chronic diseases using 
miniaturised, implantable devices that 
can modify the electrical signals that 
pass along nerves in the body.
Thirteen of the aforementioned innovative 
companies are in the Scoreboard’s world 
top 50 R&D companies (Alphabet, Apple, 
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, 
Facebook, Gilead, GSK, Merck, Roche, Sam-
sung, Daimler and VW), two more in the 
top 70 (Biogen, Medtronic) and seven more 
in the top 550 (ARM, ASML, Cerner, Illumi-
na, Intuitive Surgical, Regeneron and Tesla). 
Many other smaller R&D companies in the 
Scoreboard are working to make important 
advances in technologies of growing impor-
tance such as fintech, gene editing, IoT, big 
data, cybersecurity, next generation batteries 
(beyond lithium) and nanotechnology.
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2.2 | Long-term performance of top R&D companies
This section analyses the behaviour of the top companies over the long-term based on 
our history database containing company data for the period 2002-2015. Results of 
companies showing outstanding R&D and economic results are underlined. 
Ranking of the top 50
Table 2.2 shows the evolution of the R&D rankings of the 
top 50 companies since the first Scoreboard in 2004 and 
most significant changes are highlighted. It is important to 
note, as stated in the previous section and in past reports, 
that the reported growth of companies is often partly due to 
mergers and acquisitions. 
There are 14 EU companies (18 in 2004) and 36 non-EU 
companies (32 in 2004) in the top 50. 
In the EU group, seven companies left the top 50 (Alcatel, 
Istituto Finanziario Industriale, Philips, Renault, BAE Sys-
tems, Peugeot and Nokia) and three companies joined the 
top 50 (Boehringer Ingelheim, Fiat Chrysler and SAP).
In the non-EU group, ten companies left the top 50 (Fujitsu, 
Canon, Matsushita Electric, NEC, Motorola, Nortel Networks, 
Wyeth, Delphi, Sun Microsystems and Toshiba) and fourteen 
companies joined the top 50 (Abbvie, Amgen, Apple, Denso, 
Nissan, Gilead Sciences, Alphabet, Huawei, LG Electronics, 
Oracle, Panasonic, Qualcomm, Takeda Pharmaceuticals, Fa-
cebook).
The distribution of the top 50 companies by main industrial 
sector and region changed from 2004 to 2014 as follows:
• Automobiles & Parts, from 13 (EU 7) to 11 (EU 5)
• Pharma & Biotech, from 11 (EU 3) to 17 (EU 4)
• ICT industries, from 13 (EU 3) to 13 (EU 2)
The EU companies that improved by at least 20 places are 
Bayer (now ranked 28th) and SAP (now 49th). 
There are 12 non-EU companies that gained more than 20 
places. They include Samsung Electronics (now 2nd), Alpha-
bet (now 4th), Huawei (now 8th), Apple (now 11th), Oracle (now 
19st), Qualcomm (now 25th), Takeda (now 50th), LG Electro-
nics (now 48th), Gilead Sciences (now 46th), Bristol-Myers 
Squibb (now 20th), Celgene (now 41st), Facebook (29th).
Two companies dropped twenty or more places but remai-
ned within the top 50: Sony (now 39th) and Panasonic (now 
40th).
There are 14 companies within the top 50 that have redu-
ced R&D but only one of these is from the EU. There are 
also two with losses in 2015/16 (one from the automotive 
sector) and six whose profitability is below 5% (three from 
the automotive sector).
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FIGURE 2.1 - THE WORLD’S TOP 50 COMPANIES BY THEIR TOTAL R&D INVESTMENT (€M) IN THE 2016 SCOREBOARD.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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rank on 
2016 company country
r&d in 2015 
(€bn)
r&d intensity 
(%)
rank change 
2004-2016
1 VOLKSWAGEN Germany 13.6 6.4 up 7
2 SAMSUNG ELECTRONICS South Korea 12.5 8.0 up 31
3 INTEL US 11.1 21.9 up 11
4 ALPHABET US 11.1 16.0 up > 200
5 MICROSOFT US 11.0 14.1 up 8
6 NOVARTIS Switzerland 9.0 19.4 up 14
7 ROCHE Switzerland 8.6 19.4 up 11
8 HUAWEI China 8.4 15.0 up > 200
9 JOHNSON & JOHNSON US 8.3 12.9 up 3
10 TOYOTA MOTOR Japan 8.0 3.7 down 5
11 APPLE US 7.4 3.5 up 93
12 PFIZER US 7.0 15.7 down 10
13 GENERAL MOTORS US 6.9 4.9 down 7
14 DAIMLER Germany 6.5 4.4 down 11
15 MERCK US US 6.4 17.7 up 14
16 FORD MOTOR US 6.2 4.5 down 15
17 CISCO SYST EMS US 5.7 12.6 up 13
18 HONDA MOTOR Japan 5.5 4.9 down 7
19 ORACLE US 5.3 15.6 up 27
20 BRISTROL-MYERS SQUIBB US 5.3 34.8 up 22
21 SANOFI France 5.2 15.2 down 5
22 ASTRAZENECA UK 5.2 23.0 up 3
23 ROBERT BOSCH Germany 5.2 7.4 up 5
24 BMW Germany 5.2 5.6 up 5
25 QUALCOMM US 5.0 21.7 up 67
26 SIEMENS Germany 4.8 6.4 down 21
27 IBM US 4.5 6.0 down 17
28 BAYER Germany 4.4 9.4 up 32
29 FACEBOOK US 4.4 26.9 up > 200
30 GLAXOSMITHKLINE UK 4.2 12.9 down 19
31 FIAT CHRYSLER Italy 4.1 3.7 new
32 NISSAN MOTOR Japan 4.1 4.4 up 2
33 ABBVIE US 3.9 18.6 new
34 GENERAL ELECTRIC US 3.9 3.6 up 3
35 ERICSSON Sweden 3.8 14.2 down 18
36 ELI LILLY US 3.7 20.0 up 5
37 AMGEN US 3.6 18.2 unchanged
38 AIRBUS The Netherlands 3.6 5.6 down 3
39 SONY Japan 3.6 5.8 down 24
40 PANASONIC Japan 3.4 6.0 down 33
41 CELGENE US 3.4 39.9 up >200
42 HP US 3.2 3.4 down 19
43 DENSO Japan 3.0 8.8 down 8
44 BOEHRINGER SOHN Germany 3.0 20.3 up 18
45 BOEING US 2.8 3.2 up 12
46 GILEAD SCIENCES US 2.8 9.2 up 320
47 TOSHIBA Japan 2.8 6.4
48 LG ELECTRONICS South Korea 2.7 6.1 up 62
49 SAP Germany 2.7 12.9 up 21
50 TAKEDA PHARMA Japan 2.6 19.1 up 23
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TABLE 2.1 – THE TOP 50 COMPANIES IN 2016 SCOREBOARD: RANK CHANGE 2004-2016 (ON PREVIOUS PAGE) 
Note: companies in “blue” went up more than 20 ranks and in “red” lost more than 20 ranks  
Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
2.3 | Ranking of large companies by R&D intensity
This section examines the subset of the 50 highest R&D 
intensity large companies. These are companies where 
R&D is a very substantial component of sales and profits 
and the selected companies are therefore almost all 
drawn from the R&D-intensive ICT and biopharma sectors. 
The criteria for compiling the list are:
• R&D should be over €1bn so we are choosing 
companies from the top 137 companies in the world 
by size of R&D investment and
• R&D intensity (R&D to sales ratio) should be 10% 
or more so that R&D is a major investment and 
significant driver of growth 
The top 50 are shown in Table 2.2 which lists the 
companies with their sectors and R&D intensities together 
with the number of places they have moved up or down 
compared to the top 50 drawn from the 2015 Scoreboard. 
Six new companies appear in the top 50 this year: Allergan, 
Baidu, Electronic Arts, Seagate Technology, SK Hynix and 
Syngenta. Two of the six (Electronic Arts and Allergan) 
had R&D below €0.9bn last year while the other four all 
had R&D intensity below 10%. These six replace Bosch, 
Broadcom, eBay, Gilead Sciences, Marvell Technology and 
Texas Instruments which do not meet one or both of the 
criteria this year.
The main general conclusions are: 
• 25 of the companies in the table are also in the 
top 50 by amount of R&D (all 25 therefore have 
R&D>€2.6bn)
• The US contributes 23 of the top 50, the EU 15, Japan 
4 and others 8 (3 from Switzerland, 3 from China and 
one each from S. Korea and Taiwan). Two of the EU 
companies have their operational centres in the US but 
are headquartered in Ireland (Allergan and Seagate 
Technology) and are classed as EU companies under 
the Scoreboard's standard methodology. Allergan was 
acquired by Actavis Inc of the US in 2015 and then 
changed the name of the combined company from 
Actavis back to Allergan plc with registered office in 
Ireland.
• Biopharmaceuticals accounts for 22 of the 50 
companies (of which 6 can be classed as biotech – 
Amgen, Biogen, Celgene together with AstraZeneca, 
Bristol-Myers and Merck US; the last three having built 
up their biotech pipelines)), IT hardware (including 
telecom equipment) for 16 companies, software/
internet 9 and just 3 others (two agri-science firms 
classed as chemicals and one aerospace). The 
biopharmaceuticals companies are drawn from 
the US (10), EU (6), Japan (4) and Switzerland (2) but 
five of the six biotech companies are from the US.
• The US strength in high technology sectors such 
as biotech, software and hardware (ex telecom 
equipment) means that it contributes 8 of the top 
10 companies in the table and 19 of the total of 28 
companies in these three sectors (including Seagate). 
Japan, on the other hand, has no top 50 companies 
in these three sectors with all its four entries all being 
pharmaceuticals firms.
There are twelve sizeable changes in rankings from last 
year where companies have moved up or down by five or 
more places. Four of these were big increases in ranking 
with three of them caused by double-digit increases in 
R&D (AbbVie, AstraZeneca and Mediatek). The fourth was 
Novartis where sales were down more than R&D as it 
sold off smaller, less R&D-intensive divisions and bought 
in cancer treatments from GSK. Of the eight large falls in 
ranking, four were driven by decreases in R&D while the 
others increased sales faster than R&D.
A number of companies have shown very big increases in 
R&D and/or R&D intensity since last year. These include 
four pharma/biotech companies (Allergan, AstraZeneca, 
Bristol-Myers Squibb and Celgene), Baidu and Facebook 
from software and Huawei and ZTE in hardware. The 
largest increases in R&D are by Allergan (146.6% by 
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acquisition), Facebook (80.6%), Celgene (60.7%), Baidu 
(46.2%), Huawei (46.1%), Bristol-Myers Squibb (38.5%), 
ZTE (34.1%), AbbVie (29%), SK Hynix (23.8%) and Alphabet 
(22.4%). These are very large increases for companies 
with high R&D intensities. Note that three of the ten are 
from China where large technological companies are now 
realising the importance of R&D investment for growth.
AstraZeneca and Bristol-Myers Squibb are two of the top 
companies working on cancer immunotherapy in which 
biotech drugs are used to enable the body’s immune 
system to attack cancer cells. They are putting substantial 
R&D investment into developing their pipelines of such 
drugs with AstraZeneca’s R&D intensity up from 19.4% 
last year to 23% this year and BMS’s up from 26.2% to 
34.6%. Other companies active in cancer immunotherapy 
include Merck US (R&D intensity 17.7%), Roche and 
Novartis (both with 19.4%). Roche’s acquisition of US 
biotech Genentech gave it biotech and immunotherapy 
expertise. Celgene has the largest R&D intensity in the 
table at 39.9%; this reflects its extensive pipeline of 55 
clinical trials of potential drugs with 37 of these aimed at 
a range of cancers.
Facebook has increased its R&D by 80.6% to €4.4bn and 
its R&D intensity from 21.4% last year to 26.8% this year 
as it develops its leading social media platform. Alphabet 
and Facebook together account for 64% of the growing 
US digital advertising market with Alphabet’s share nearly 
four times Facebook’s. Alphabet’s share of the global 
digital ad market for 2016 is put at 31% by eMarketer. 
Baidu, the Chinese equivalent of Google search, Google 
maps, Wikipedia and other web services, was founded 
by two Chinese experts who had worked in the US. The 
company has a large market share in China since it 
accepts government censorship which many western web 
companies will not. Baidu increased its R&D by 46.2% this 
year to €1.44bn. However, Alphabet’s R&D is nearly eight 
times larger at €11.1bn and its R&D intensity is somewhat 
higher (16% vs. 15.4%).
EU companies are represented in the top 50 by six 
from biopharma (AstraZeneca, Boehringer Ingelheim, 
GlaxoSmithKline, Merck (DE), Novo Nordisk and Sanofi), five 
from technology hardware/telecom equipment (Alcatel-
Lucent, ASML, Ericsson, Nokia, ST Microelectronics) with one 
each from software (SAP) and aerospace (Finmeccanica). 
ASML is the clear world leader in precision lithography, the 
key step in making all semiconductor chips, Novo Nordisk 
is world leader in treatments for diabetes, the world’s 
fastest-growing major disease, and AstraZeneca is one of 
the four world leaders in immuno-oncology.
TABLE 2.2 (ON NEXT PAGE) – RANKING OF LARGE COMPANIES BY R&D INTENSITY 
Note1: Colour of names of companies indicate country/world region as in Figure 2.1, except Mediatek (n black) from Taiwan.
Note 2: EMC was acquired by Dell in 2016 and is now part of Dell Technology; the acquisition of EMC is the largest ever acquisition of a tech company.
Source: The 2016 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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rank by 
r&d int.
rank by 
r&d 2015 company sector
r&d int. 
2015 (%)
rank 
change
reasons for big 
changes (up or down 
5 places or more)
1 41 CELGENE Biotech 39.9 0
2 20 BRISTOL-MYERS SQUIBB Pharma 34.8 3
3 29 FACEBOOK Internet 26.9 4
4 111 NVIDIA IT hardware 26.6 -2
5 131 ELECTRONIC ARTS Software 25.2 NEW Sales down >R&D up
6 124 YAHOO! Internet 24.3 -2
7 94 MEDIATEK IT hardware 23.2 5 Sales level, R&D up
8 22 ASTRAZENECA Pharma 23.0 8 R&D up 12.3, sales -6.9%
9 3 INTEL It hardware 21.9 2
10 25 QUALCOMM IT hardware 21.7 -1
11 81 DAIICHI SANKYO Pharma 21.2 -2
12 44 BOEHRINGER SOHN Pharma 20.3 2
13 36 ELI LILLY Pharma 20.0 0
14 6 NOVARTIS Pharma 19.4 9 Sales -15%, R&D -9.5% (GSK deal)
15 7 ROCHE Pharma 19.4 2
16 50 TAKEDA PHARMA Pharma 19.1 -10 R&D -9.5%, sales +5.1%
17 68 BIOGEN IDEC Biotech 18.7 -2
18 33 ABBVIE Pharma 18.6 7 R&D up more than sales
19 54 NOKIA IT hardware 18.4 -1
20 37 AMGEN Biotech 18.2 -12 R&D down, sales up
21 119 STMICROELECTRONICS IT hardware 18.1 0
22 60 ALLERGAN Pharma 15.0 NEW Merger Actavis & Allergan
23 15 MERCK US Pharma 17.7 -3
24 57 ALCATEL-LUCENT IT hardware 16.9 1 Controlled by Nokia since 01/2016
25 129 ASML HOLDING IT hardware 16.6 -6
26 74 ASTELLAS PHARMA Pharma 16.4 -2
27 4 ALPHABET IT services 16.0 2
28 12 PFIZER Pharma 15.7 -6
29 19 ORACLE Software 15.6 2
30 92 BAIDU Internet 15.4 NEW R&D +46.2%, sales +35.3%
31 21 SANOFI Pharma 15.2 3 R&D up more than sales
32 103 APPLIED MATERIALS IT hardware 15.0 -4 R&D up 1.6% but sales up 6.5%
33 8 HUAWEI IT hardware 15.0 3
34 35 ERICSSON IT hardware 14.2 -7 R&D down, sales up
35 5 MICROSOFT Software 14.1 5 R&D level, sales down 8.8%
36 85 OTSUKA Pharma 13.9 -1
37 64 ZTE IT hardware 13.8 4 R&D +34.1%, sales up 23%
38 76 MERCK DE Pharma 13.3 -8 R&D level, sales up
39 30 GLAXOSMITHKLINE Pharma 12.9 -2
40 49 SAP Software 12.9 -1
41 9 JOHNSON & JOHNSON Pharma 12.9 3 R&D + 6.5%, sales -5.75%
42 17 CISCO SYSTEMS IT hardware 12.6 -1
43 86 WESTERN DIGITAL IT hardware 12.5 2
44 72 NOVO NORDISK Pharma 12.0 -13 R&D level, sales up 21.5%
45 121 SEAGATE TECHNOLOGY IT hardware 11.1 NEW Sales fell more than R&D
46 55 EMC IT hardware 10.7 -15
47 98 FINMECCANICA Aerospace 10.6 2
48 91 MONSANTO Chemicals 10.5 -2
49 84 SK HYNIX IT hardware 10.5 NEW R&D +23.8%, sales +9.8%
50 107 SYNGENTA Chemicals 10.2 NEW Sales down more than R&D
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3 R&D DISTRIBUTION BY INDUSTRIAL SECTOR
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This chapter presents the main R&D trends among the 2016 Scoreboard companies 
aggregated by industrial sectors8. It comprises the ranking of sectors by their level of 
R&D investment, R&D intensities, rates of R&D growth and the comparison of such 
trends across world regions. 
Key findings
• Companies from Software & Computer Services, dri-
ven by the US companies, showed the highest R&D 
growth (12.3%). The top two R&D investing sectors 
achieved a fair increase of R&D and are Pharmaceu-
ticals & Biotechnology (9.8%) and Technology Hard-
ware & Equipment (7.6%). The Automobile & Parts 
sector grew R&D at a rate similar to the all-sector 
average rate (6.6%). All the other large sectors increa-
sed R&D below the world average, e.g. Electronic & 
Electric Equipment (5.5%) and Health Care Equipment 
and Services (5.0%); and those showing the poorest 
performance were Chemicals (2.3%) and Aerospace 
& Defence (1.2%). 
• In the Pharmaceuticals & Biotechnology sector, com-
panies operating in biotechnology increased R&D by 
23.8% whereas the traditional pharmaceutical com-
panies increased it only by 7.2%. As observed in pre-
vious editions, this is due to the rapid development 
of biotechnology, illustrated by an outstanding perfor-
mance of the top biotechnology companies, most of 
the world's large biotechs being based in the US. 
• Among the top 5 sectors, companies based in the 
EU had the highest R&D growth in Pharmaceuticals 
& Biotechnology (13.2%) and Software & Computer 
Services (12.2%). The highest R&D growth in the EU 
was showed by the Health Care Equipment and Ser-
vices (20.7%), mainly due to the largest company in 
that sector, Medtronic (a US company headquartered 
in Ireland), that increased R&D by 35.5% due to its 
acquisition of Covidien (another US company with re-
gistered office in Ireland).
• Trends observed in the Scoreboard over the last 12 
years show a characteristic, but very different indus-
trial specialisation of the EU and US companies that 
persists after the financial crisis and appears to have 
been reinforced over the past few years:
 ◦ Concentration of the EU companies in me-
dium-high R&D intensity sectors (total domes-
tic and sector world R&D shares of 44.7% and 
33.7% respectively). In particular in Automobi-
les & Parts with domestic and world R&D sha-
res of 27.0% and 46.5% respectively. 
 ◦ Dominance of US companies in high R&D-in-
tensity sectors (total domestic and sector world 
R&D shares of 75.7% and 54.5% respectively). 
In particular in ICT industries with total domes-
tic and sector world R&D share of 45.8% and 
67.1% respectively. 
8 According to the Industry Classification Benchmark (ICB) applied in the Scoreboard.
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3.1 | General R&D trends
Figure 3.1 shows the R&D rankings of companies from the 
main industrial sectors including the relative R&D share by 
main world region. The specialisation of the main world 
regions, represented by the share of sectors within the re-
gions' total R&D investment, is given in figure 3.2.
• R&D investment in the Scoreboard remains highly 
concentrated by sectors: out of 38 industrial sectors, 
the top three –Pharmaceuticals & Biotechnology, Au-
tomobiles & Parts and Technology Hardware & Equip-
ment– account for 49.0% of the total R&D investment 
by all the Scoreboard companies. 
The top 6 and top 15 sectors constitute, respectively, 
72.0% and 91.6% of the total R&D in the Scoreboard. 
A similar concentration of R&D in a relatively small 
number of industrial sectors has been observed over 
the last 13 years.
• The ranking by R&D investment of the top 15 sectors 
remained unchanged.
• The Pharmaceuticals & Biotechnology sector keeps its 
first position in the R&D ranking, increasing its share 
of the total R&D investment to 19.1%. It is followed 
by the Automobile & Parts (15.6%) and Technology 
Hardware & Equipment (14.4%) sectors. 
• The R&D specialisation (share of R&D investment) of 
the main regions in the top 3 sectors are: 
 ◦ In the EU, Automobiles & Parts (27.0%), Pharma-
ceuticals & Biotechnology (19.6%), and Techno-
logy Hardware & Equipment (6.9%); 
 ◦ In the US, Technology Hardware & Equipment 
(23.3%), Pharmaceuticals & Biotechnology (22.9%) 
and Software & Computer Services (22.8%);
 ◦ In Japan, Automobiles & Parts (29.4%), Electro-
nic & Electrical Equipment (13.0%) and Phar-
maceuticals & Biotechnology (10.6%). 
• The contribution to the total Scoreboard R&D:
 ◦ by EU companies is 46.5% to Automobiles & 
Parts, 46.2% to Aerospace & Defence, and 
32.0% to the Industrial Engineering sectors; 
 ◦ the US contributes 77.2% to Software & Com-
puter Services, 57.7% to Technology Hardware 
& Equipment and 55.1% to Health Care Equip-
ment & Services; 
 ◦ Japan contributes 61.4% to Leisure Goods, 30.0% 
to Chemicals, and 29.6% to General Industrials.
3.2 | R&D growth by industrial sector
The actual contribution of an industrial sector to the overall 
R&D growth of a region depends on both its rate of R&D 
change and the sector's share of the total R&D of the region. 
Figures 3.1 and 3.2 show the shares of the main industrial 
sectors and table 3.1 shows their ranking by R&D growth 
worldwide for the Scoreboard companies based in the main 
world regions.
The following points are observed for the top 11 sectors 
accounting for 91.5% of the total R&D investment of the 
Scoreboard companies:
• Worldwide, the Software & Computer Services sector 
shows the highest one-year growth rate (12.3%) fo-
llowed by Pharmaceuticals & Biotechnology (10.0%) 
and Technology Hardware and Equipment (7.6%) sec-
tors. The R&D growth rate of the Software & Computer 
Services sector is mostly due to the R&D growth of US 
companies such as Alphabet (22.4%) and Facebook 
(80.6%) and Chinese companies such Baidu (46.2%). 
The German company SAP (16.6%) is the fourth contri-
butor to the R&D growth of this sector9. 
• Among the companies based in the EU, most of the top 
R&D investing sectors showed high R&D growth (excep-
ting Technology Hardware and Equipment). The highest 
contribution to R&D growth was shown by Automobiles 
& Parts (9.2%), driven by German companies such as 
9 Taking into account the R&D weight of the company within the sector and its R&D growth in 2015.
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Daimler (15.6%) and BMW (13.2%). Pharmaceuticals & 
Biotechnology was the second R&D growth contributor 
(13.2%) with big pharma companies showing very high 
R&D growth (excepting GlaxoSmithKline, -0.5%), e.g. 
Allergan (146.6% through acquisition), Bayer (20.2%) 
and AstraZeneca (12.3%). Other EU sectors showing 
double-digit R&D growth are Health Care Equipment & 
Services (20.7% driven by acquisition), Software & Com-
puter Services (12.2%). Most large EU software com-
panies had double-digit R&D growth, e.g. SAP, UBISOFT 
ENTERTAINMENT, EYGS, DASSAULT SYSTEMES, MICRO 
FOCUS INTERNATIONAL, PLAYTECH, GAMELOFT, AVG 
TECHNOLOGIES AND COMPUTATIONAL DYNAMICS. 
Sectors showing the lowest R&D growth in 2015 were 
Industrial Engineering (-1.7%) and Aerospace & Defen-
ce (-0.8%).
• Among the companies based in the US, the Pharma-
ceuticals & Biotechnology and Leisure Goods sectors 
show the highest one-year growth rate (13.0%) fo-
llowed by Software & Computer Services (11.5%). Sec-
tors showing the lowest one-year R&D growth are Che-
micals (-3.8%) and Health Care Equipment & Services 
(-3.1%).
• For Japanese companies, the highest one-year grow-
th rate is shown by Health Care Equipment & Services 
(10.9%) followed by Industrial Engineering (9.6%). The 
poorest performance was shown by Software & Com-
puter Services (-8.3%) and Leisure Goods (0.2%).
• For the Chinese companies, all the top 11 sectors 
showed double-digit R&D growth, including the largest 
R&D industries such as Software & Computer Services 
(38.3%), Technology Hardware & Equipment (35.0%) 
and Industrial Engineering (24.8%).
Apart from the top 11 industries, there were important R&D 
changes in some other sectors:
• In the smaller sectors in terms of R&D, significant R&D 
growth was shown by Banks (15.1%) mainly due to 
double-digit R&D growth reported by EU banks such as 
BANCO SANTANDER, BARCLAYS and DEUTSCHE BANK. 
Also the Construction & Materials sector showed an im-
portant R&D increase (20.7%), mostly due to Chinese 
companies.
• Oil and mining related sectors, on the other hand, de-
creased R&D as oil and commodity prices fell: Oil & Gas 
Producers (-14.5%), Oil Equipment, Services & Distribu-
tion (-12.1%) and Mining (-19.7%).
• The Alternative Energy sector reversed the negative 
trend of the past few years showing an increase of 
7.7% in 2015. 
• In 2015, the Industrial Transportation sector continued 
the positive trend of the past year, increasing signifi-
cantly R&D (18.2%).
FIGURE 3.1 -  R&D RANKING OF INDUSTRIAL SECTORS AND SHARE OF MAIN WORLD REGIONS FOR THE WORLD’S TOP 2500 COMPANIES.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.2 -  R&D SHARES OF SECTORS OF THE MAIN WORLD REGIONS
TABLE 3.1. RANKING OF TOP 11 INDUSTRIAL SECTORS BY OVERALL ONE-YEAR R&D GROWTH IN THE 2016 SCOREBOARD.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
sector Global R&D Growth (%) EU USA Japan China
Software & Computer Services 12.3 12.2 11.5 -.8.3 38.3
Pharma & Biotechnology 9.8 13.2 13.0 2.3 27.5
Technology Hardware & Equip. 7.6 0.0 5.1 .47 35.0
Automobiles & Parts 6.7 9.2 -0.6 5.5 14.2
Electronic & Electrical Equipment 5.5 9.6 3.1 3.7 23.7
Health Care Equip. & Services 5.0 20.7 -3.1 10.9 14.1
General Industrials 3.7 10.6 0.5 0.6 14.7
Industrial Engineering 3.3 -1.7 -1.4 9.6 24.8
Leisure Goods 2.9 7.5 13.0 0.2 15.8
Chemicals 2.3 6.7 -3.8 5.0 28.0
Aerospace & Defense 1.2 -0.8 2.8 2.0 44.7
Top 11 IndustriIes 7.3 8.2 7.0 3.7 28.6
Other Industries 1.8 4.6 -.68 -0.1 15.4
All Industries 6.6 7.5 5.9 3.3 24.7
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3.3 | R&D intensity by sector
Table 3.2 provides the list of industrial sectors ranked by 
worldwide R&D intensity of the main industrial sectors for 
the 2500 Scoreboard companies grouped by main world 
region. 
The following points are observed:
• Most industrial sectors increased their R&D intensity 
as R&D investment increased more than net sales 
in 2015/16, e.g. Pharmaceuticals & Biotechnology 
(14.8 % vs. 14.4%) and Technology Hardware & 
Equipment (8.3% vs. 8.0%). The opposite happe-
ned for Health Care Equipment & Services (3.6% vs. 
3.8%).
• Four sectors have an R&D intensity of more than 5.0%: 
Pharmaceuticals & Biotechnology, IT sectors (Softwa-
re & Computer Services and Technology Hardware & 
Equipment) and Leisure Goods (mainly electronic lei-
sure). The sector with the lowest R&D intensity is Oil 
& Gas Producers (0.3%). 
• Among the top 11 sectors, the R&D intensity of EU 
companies is larger than that of the US and Japan in 
5 sectors (Electronic & Electrical Equipment, Technolo-
gy Hardware & Equipment, General Industrials, Auto-
mobiles & Parts and Aerospace & Defence). Japanese 
companies show higher R&D intensity than the EU and 
the US in sectors such as Leisure Goods, Health Care 
Equipment & Services and Chemicals. The R&D inten-
sity of US companies is higher than that of the EU and 
Japan in Pharmaceuticals & Biotechnology, Software 
& Computer Services and Industrial Engineering.
• As observed in previous Scoreboards, the overall lower 
average of R&D intensity of the EU companies is due 
to their large share of low R&D-intensive sectors with 
very large sales such as Oil & Gas, Mining, Banks, as 
compared to a similar group of non-EU companies. 
Conversely, the high average R&D intensity of the US 
companies is due to their considerable weight in high 
R&D-intensive sectors (see Figures 3.1 and 3.2 and 
Table 3.4).
sector Global R&D Intensity (%) EU USA Japan China
Software & Computer Services 15.0 13.8 18.7 11.8 2.7
Pharma & Biotechnology 10.6 10.2 14.7 1.9 10.2
Technology Hardware & Equip. 8.4 15.1 9.3 5.2 6.7
Automobile & Parts 5.9 2.7 5.8 5.9 5.1
Electronic & Electrical Equipment 4.7 5.3 4.2 4.5 4.3
Health Care Equip. & Services 4.3 5.4 4.1 4.0 2.4
General Industrials 4.3 5.4 3.1 1.4 3.1
Industrial Engineering 3.6 5.1 2.8 8.0 7.8
Leisure Goods 3.2 3.1 3.3 3.0 3.8
Chemicals 2.9 2.2 3.6 3.9 2.0
Aerospace & Defense 2.8 4.8 3.1 3.0 2.2
Top 11 Industries 6.0 6.3 7.6 4.3 4.5
Other Industries 1.1 1.0 1.5 1.1 1.2
All Industries 3.8 3.2 5.8 3.3 2.5
TABLE 3.2 - RANKING OF THE TOP 11 INDUSTRIAL SECTORS BY OVERALL R&D INTENSITY IN THE 2016 SCOREBOARD
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
58 The 2016 EU Industrial R&D Scoreboard
3.4 | Growth of net sales by industrial sector and main world region
Table 3.3 shows the ranking of the top 11 industrial sectors 
by overall one-year growth of net sales for the companies 
based in the EU, the US, Japan and the RoW group. These 
sectors account for 86.7% of the total R&D and 51.8% of 
the total net sales. The following points are observed:
• The majority of large R&D investing sectors increased 
net sales. Worldwide, the Automobiles & Parts shows 
the highest one-year growth rate of net sales (7.9%) 
followed by Health Care Equipment & Services (7.5%) 
and Software & Computer Services (5.4%).
• Among the small R&D investing sectors (but large in 
terms of net sales), a significant decrease in net sa-
les was driven by the fall of oil and commodity pri-
ces. Oil-related industries reduced net sales by almost 
30% and mining industries by more than 20%.
• Among the companies based in the EU, the highest 
growth rates of net sales are in Health Care Equipment 
& Services (21.2%) and Leisure Goods (20.7%). The sec-
tor showing the lowest one-year sales growth is Indus-
trial Engineering (-4.7%) and Chemicals (-3.8%). Among 
the largest sectors in the EU, the highest profitability 
is shown in Pharmaceuticals & Biotechnology (17.9%) 
followed by and Health Care Equipment & Services 
(14.2%) and Software & Computer Services (13.6%). 
• Among the companies based in the US, Technology 
Hardware & Equipment shows the highest one-year 
growth rate for sales (5.9%) followed by Pharmaceu-
ticals & Biotechnology (4.1 %). Sectors showing the 
lowest one-year R&D growth are Industrial Enginee-
ring (-10.4%) and Chemicals (-8.3%). The US-based 
companies have the highest profitability in Pharma-
ceuticals & Biotechnology (26.3%), Technology Hard-
ware & Equipment (19.8%) and Software & Computer 
Services (18.1%). 
• For Japanese companies, the highest one-year growth 
rate for sales is shown by Pharmaceuticals & Biotechno-
logy (9.1%) and Automobiles & Parts (6.5%). The poorest 
performance is shown by General Industrials (-6.3%). 
The profitability of companies based in Japan is genera-
lly lower than their counterparts in the EU and the US, for 
example 10.5% for Pharmaceuticals & Biotechnology. 
The highest profitability sector for Japanese companies 
is Health Care Equipment & Services (15.5%).
TABLE 3.3 - RANKING OF TOP 11 INDUSTRIAL SECTORS BY SALES GROWTH IN THE 2016 SCOREBOARD.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
sector overall sales change (%)
eu sales 
change
us sales 
change
japan 
sales 
change
china 
sales 
change 
Automobiles & Parts 7.9 13.4 -0.2 6.5 10.0
Health Care Equipment & Services 7.5 21.2 3.8 6.4 20.1
Software & Computer Services 5.4 12.6 1.6 2.6 28.2
Technology Hardware & Equipment 4.9 1.6 5.9 0.1 13.6
Pharmaceuticals & Biotechnology 4.9 7.3 4.1 9.1 9.2
Aeropace & Defence 2.8 5.8 1.5 5.6 -4.5
Electronic & Electrical equipment 2.8 4.8 2.0 1.8 15.5
Leisure Goods -0.7 20.7 2.7 -1.2 7.5
General Industrials -2.8 3.9 -3.2 -6.3 -1.3
Industrial Engineering -5.4 -4.7 -10.4 4.2 -2.0
Chemicals -7.2 -3.8 -8.3 -1.4 4.7
Top 11 Industries 2.7 6.9 0.7 2.5 8.3
Other Industries -10.4 -9.7 -13.6 -4.2 -13.8
All Industries -3.6 -3.6 -4.0 0.3 -6.2
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3.5 | Changes in indicators by region and sector groups
It is interesting to see the distribution of R&D investment 
of the Scoreboard companies across regions and sectors 
using an aggregation of the 38 industrial sectors into four 
groups of high-, medium-high-, medium-low- and low- 
R&D intensity (see Box 1.1 in chapter 1).
The worldwide and domestic distribution of the R&D in-
vestment by the 2500 Scoreboard companies shows clear 
differences by world region, illustrating respectively the 
weight of the region in the world and its specialisation 
(See Table 3.4): 
• Companies based in the EU specialise in medium-hi-
gh R&D-intensive sectors (44.7% of total R&D of 
the EU companies) and contribute 33.7% of the to-
tal world R&D of that sector group (compared to the 
EU’s 27.0% of total world R&D). EU Industrial sec-
tors accounting for a large share of total world R&D 
of their sector are Automobiles & Parts (46.5%), 
Aerospace & Defence (46.2%) and Industrial Engi-
neering (32.1%). 
• Those based in the US specialise in high R&D intensive 
sectors (75.7% of total R&D of the US companies) and 
contribute 54.5% of the world R&D of that sector group. 
Industrial sectors accounting for a large share of total 
world R&D of these sectors are Software & Computer 
Services (77.2%), Technology Hardware & Equipment 
(57.7%) and Health Care Equipment & Services (55.1%) 
compared to the US’s 38.6% of total world R&D.
• Japanese companies specialise in medium-high R&D 
intensive sectors (61.9% of total domestic R&D) whi-
le contributing 24.8% of the world R&D of that sec-
tor group. The industrial sectors with highest weight 
in the total world R&D are Leisure Goods (61.4%), 
General Industrials (29.5%) and Chemicals (30.0%) 
compared to Japan’s 14.4% share of total world R&D.
Region
sector
high share (%) medium-high share (%)
medium-low 
share (%) low share (%) region’s 
world 
share (%)world domestic world domestic world domestic world domestic
EU 19.8 39.3 33.7 44.7 36.8 5.4 44.0 10.6 27.0
US 54.5 75.7 20.8 19.4 33.9 3.5 8.4 1.4 38.6
Japan 8.1 30.2 24.8 61.9 14.7 4.1 8.3 3.8 14.4
China 5.9 44.1 6.2 31.0 2.7 1.5 25.7 23.4 7.2
TABLE 3.4 - WORLD AND DOMESTIC R&D DISTRIBUTION OF THE 2016 SCOREBOARD COMPANIES BY SECTOR GROUPS FOR THE MAIN REGIONS
Note : Sector groups as defined in Box 1.1.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
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4 THE TOP 1000 R&DINVESTORS IN THE EU
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This chapter discusses the R&D and economic trends of companies based in Member 
States of the EU. This specific analysis is based on an extended sample of companies 
representing the top 1000 R&D investors in the EU, i.e. the 590 EU companies included 
in the world top 2500 sample and 410 additional companies based in the EU, all of 
which have R&D of €6m or more. The main questions addressed are firstly about the 
one-year changes in R&D and economic indicators of companies based in the top 10 
Member States by level of R&D investment. The second question regards the long-term 
trends of company results, namely the rate of growth of R&D and net sales and profi-
tability for companies based in the three largest Member States of the EU.
Key findings
• Companies based in Germany, the top R&D investor, 
continued to increase considerably R&D in 2015, at 
10.5%, above the world (6.6%) and EU (7.4%) avera-
ges. Companies based in the UK showed a significant 
increase of R&D (4.1%), and French companies a more 
modest R&D growth rate (1.9%).
• Apart from the three top Member States, among the 
group of largest EU countries, those whose companies 
increased R&D above the EU average were Ireland 
(29.6% due to acquisitions), Italy (10.5%) and Den-
mark (8.6%). Among the large countries, only the com-
panies based in Finland decreased R&D (-3.8%). 
• The analysis of 10-year trends of R&D and economic 
results for companies based in Germany, the UK and 
France show the effects of the crisis in 2008-2009 and 
a recovery over 2010-2012, especially for the German 
companies. However over the past year the recovery 
seems to be stalling with companies from the three 
countries showing a fall in net sales. The latter is most-
ly due to the decrease of net sales of large companies 
in terms of sales but with relatively small R&D, e.g. oil 
companies (Total, Shell,BP, ENI) and banks (HSBC).
The top 1000 R&D Investors in the EU4
4.1 | Overview of the EU 1000 companies 
The composition of the sample of the EU 1000 companies 
across industrial sectors and countries is found in Annex 
3. This sample, as well as the global 2500, shows a high 
concentration of companies by sector and country. The 15 
largest sectors in terms of R&D account for 78% of the 
companies. The distribution of companies for these sec-
tors and for countries including more than 5 companies is 
shown in Table 4.1 (page 41).
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TABLE 4.1- DISTRIBUTION OF THE EU 1000 COMPANIES ACROSS MAIN SECTORS AND COUNTRIES*. 
* INCLUDING ONLY COUNTRIES WITH MORE THAN 5 COMPANIES
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
sector r&d 2015 (€ bn) 
Nr 
firms at be de dk es fi fr ie it lu nl se uk
Automobiles & Parts 50.3 47 4 18 1 6 5 2 2 9
Pharmaceuticals & 
Biotechnology 37.3 133 1 5 14 11 4 1 20 8 4 1 8 9 43
Technology 
Hardware & 
Equipment
15.2 41 2 1 6 1 2 6 1 6 5 10
Electronic & 
Electrical equipment 10.2 69 3 3 14 2 4 9 1 4 1 5 4 19
Aerospace & 
Defence 9.8 24 2 1 7 2 1 1 9
Industrial 
Engineering 9.2 104 5 2 37 3 3 7 7 2 7 2 4 11 14
Banks 9.2 33 2 7 2 2 2 2 2 2 2 7
Software & 
Computer Services 8.2 112 2 20 2 2 5 17 1 1 3 5 53
Chemicals 5.6 42 2 3 14 1 3 3 3 3 10
Health Care 
Equipment & 
Services
5.0 44 2 13 3 3 2 2 5 13
Fixed Line 
Telecommunications 4.3 10 1 1 1 1 1 1 1 2
Geneal Industrial 4.0 35 1 10 1 1 1 2 1 2 2 2 7 5
Oil & Gas Producers 2.8 8 1 1 1 1 1 2
Food Producers 2.7 26 1 2 1 2 3 2 5 8
Support Services 2.1 49 12 3 1 1 6 26
Top 15 175.9 777 22 19 170 28 15 27 90 21 28 7 44 61 230
Others 17.3 223 7 11 47 6 7 12 27 4 15 8 5 22 44
Total 193.2 1000 29 30 217 34 22 39 117 25 43 15 49 83 274
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4.2 | Trends of companies in the top 10 Member States of the EU
There are 906 companies based in the top 10 Member 
States accounting for 97.4 % of the total R&D of the 1000 
EU sample (see table 4.2). 
The overall performance of the EU group is largely driven 
by the performance of companies based in Germany, Fran-
ce and the UK, accounting for 66.7% of the total R&D and 
65.6% of total net sales (see Tables 4.2 and 4.3). 
In 2015, by far, the 217 German companies made the lar-
gest contribution to the results of the EU 1000 sample. 
These companies, accounting respectively for 36.7% and 
29.6% of the total R&D and net sales, increased R&D by 
10.5% and net sales by 8.5%. These results reflect to a 
large extent the performance of the German companies in 
the Automobiles & Parts sector (9.6% in R&D and 15.2% 
in net sales). This sector accounts for 52.3% of R&D and 
35.0% of net sales of the group of German companies. 
Among the large companies in this sector, double-digit 
R&D growth was shown by automotive sector companies 
Daimler, BMW and ZF. German companies showed also 
good performance in other sectors, namely double-digit 
R&D and net sales growth in health and ICT-related indus-
tries. In particular, double-digit R&D growth was shown by 
large German companies such as Bayer, Boehringer Sohn, 
SAP and Siemens.
The 276 companies from the UK, accounting for 15.4% 
and 19.2% of the total R&D and net sales of the EU 1000 
sample, increased R&D by 4.1% but showed a very large 
decrease in net sales (-20.9%). The largest contribution 
to R&D growth was made by the Pharmaceuticals (7.7%) 
and Banks (17.9%) sectors. The negative figure on net sa-
les is mostly due to Oil and Mining related companies (e.g. 
Shell, BP, Rio Tinto and Anglo American). 
The 117 companies based in France, accounting respecti-
vely for 15.0 % and 17.0% of the total R&D and net sales 
of the EU 1000 sample, slightly increased R&D investment 
(1.9%) and decreased net sales 3.1%. The largest contri-
bution to the R&D growth was made by the Automobiles & 
Parts (9.1%) and Pharmaceuticals & Biotechnology (6.3%) 
and the poorest performance was shown by the Industrial 
Engineering sector (-45.0%). The latter had also the worst 
performance in terms of net sales (-47.2%). 
Apart from the group of the three top countries, among 
the group of largest EU countries, those whose compa-
nies increased R&D above the EU average were Ireland 
(29.6% in R&D and 2.0% in sales), Italy (10.5% in R&D 
and 0.2% in sales), Denmark (8.6% in R&D and 8.8% in 
sales) and Spain (8.1% in R&D and -1.4% in sales). The 
outstanding R&D growth of the Irish group was largely due 
to the R&D growth of two US companies with headquar-
ters in Ireland, both of which grew substantially through 
making large acquisitions. These companies made also 
the largest contribution to the R&D growth of their sec-
tors: From the Pharmaceuticals sector, Allergan (146.7% 
after Actavis combined with Allergan) and from the Health 
Care Equipment sector, Medtronic (35.6% after Medtronic 
acquired Covidien).
Companies based in Finland continued to decrease R&D 
in 2015 (-3.8%), but a lower pace compared with 2014 
(-15.7%), mostly due to Nokia (-7.9%), which accounts for 
63.9% of the total R&D of Finnish companies. 
In term of net sales, several countries showed negative 
results, the poorest figures in net sales were for companies 
based in the UK (-20.9%), as mentioned above, mostly due 
to oil and mining related companies as the prices of these 
commodities fell. All the countries except Finland showing 
negative or near zero sales growth have large oil com-
panies (UK –BP & Shell; France – Total; Spain – Repsol; 
Italy – ENI).
It is important to remember that in many countries, the ag-
gregate country indicators depend to a large extent on the 
figures of a very few firms. This is due, either to the coun-
try's small number of companies in the Scoreboard or to 
the concentration of R&D in a few large firms. For example:
• Ericsson and Volvo account for 57.0% of the total 
R&D of the Swedish companies and therefore large-
ly determined the overall R&D growth of their group 
(1.4%). Both decreased R&D (Ericsson by 3.5% and 
Volvo by 2.4%) offsetting the good R&D figures of 
smaller companies such as Sandvik, Hexagon, Atlas 
Copco and Electrolux. 
• The Automobiles & Parts sector accounts for 52.3% of 
the R&D of companies based in Germany. Four com-
panies in this sector, accounting for 37.6 % of the Ger-
man companies' R&D, contributed a large part of that 
country's R&D growth: Daimler (515.6%), ZF (55.9%), 
BMW (13.2%) and Volkswagen (3.8%).
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TABLE 4.2 - R&D TRENDS FOR COMPANIES BASED IN THE TOP 10 EU MEMBER STATES
Note: For the sample of 1000 EU companies.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
country no. of companies
r&d in 
2015/16 (€ bn)
r&d share 
within eu (%)
r&d one year 
growth (%)
net sales 
one year 
growth (%)
Germany 217 70.8 36.7 10.5 8.5
UK 276 29.8 15.4 4.1 -20.9
France 117 28.9 15.0 1.9 -3.1
The Netherlands 49 14.3 7.4 4.2 1.1
Italy 45 12.4 6.4 10.5 0.2
Sweden 83 10.0 5.2 1.4 7.6
Ireland 24 8.8 4.6 29.6 2.0
Spain 22 4.7 2.5 8.1 -1.4
Denmark 34 4.4 2.3 8.6 8.8
Finland 39 3.9 2.0 -3.8 -4.0
Top 10 countries 906 188.2 97.4 7.4 -2.9
Other countries 94 5.0 2.6 6.9 -9.4
Total EU 1 000 193.2 100.0 7.4 -3.2
TABLE 4.3 - GROWTH OF R&D AND NET SALES FOR THE FOR GERMAN, FRENCH AND UK COMPANIES BREAK DOWN BY INDUSTRIAL SECTOR.
Note: For the sample of 1000 EU companies
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD
industry eu 1000 r&d (€bn)
germany 1-year 
change (%)
france 1-year 
change (%)
uk 1-year 
change (%)
r&d sales r&d sales r&d sales
Automobiles & Parts 50.3 9.6 15.2 9.1 8.8 -4.0 -0.6
Pharmaceuticals & Biotechnology 37.3 13.6 11.4 6.3 3.5 7.7 0.1
Technology Hardware & Equipment 15.2 20.7 28.3 5.6 5.3 0.9 9.4
Electronic & Electrical Equipment 10.2 10.1 5.8 7.6 6.7 10.2 8.6
Aerospace & Defence 9.8 6.8 11.1 -3.4 14.6 4.6 2.5
Industrial Engineering 9.2 11.2 8.6 -45.0 -47.2 0.7 -12.5
Banks 9.2 22.7 3.1 8.9 6.6 17.9 -11.9
Software & Computer Services 8.2 14.5 13.6 15.6 15.6 9.7 7.9
Chemical 5.6 4.1 -0.7 22.4 12.9 10.2 4.4
Health Care Equipment & Services 5.0 12.5 15.9 28.4 18.5 4.5 4.7
Fixed Line Telecommunications 4.3 10.9 10.5 -0.8 2.0 -38.8 6.0
General Industrials 4.0 1.7 -11.2 11.8 13.6 0.9 3.3
Top 12 industries 168.3 10.6 10.6 5.3 4.3 5.9 -4.5
Other industries 24.9 9.4 4.2 -10.0 -8.0 -2.9 -27.3
Total 193.2 10.5 8.5 1.9 -3.1 4.1 -20.9
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The annual growth rates of R&D investment, net sales 
and profitability of companies based in Germany, France and 
the UK is provided respectively in figures 4.1, 4.2 and 4.3 
for the period 2006-2015. These figures are based on our 
history database comprising R&D and economic indicators 
over the whole 2006-2015 period from the EU 1000 data-
set, including 159 from Germany, 87 from France and 165 
from the UK. 
The trends observed in these figures show the behaviour 
of these companies including the effects of the crisis that 
began in 2008. The following points are observed: 
• Companies based in Germany showed a good per-
formance over the period 2010-2012, recovering the 
levels of growth prior to the crisis, especially in terms 
of R&D. In the last period, they continued to increase 
R&D at a rapid pace, maintaining a stable but low le-
vel of profitability and showing an outstanding recent 
recovery in term of net sales since Germany has no 
large oil or mining companies. 
• Companies based in France showed a recovery in R&D 
and net sales in 2010-2011, however, over the period 
2012-2014 they presented an important decline in 
R&D growth and also an important decrease in the 
growth rate of net sales. Over the last period French 
companies show a modest recovery of R&D growth 
but with the rate of growth of net sales still declining. 
The average profitability of the French companies 
shows a decreasing trend since 2011 that seems to 
stabilise over the last period.
• Companies based in the UK showed a strong reco-
very of R&D and net sales in 2010-2011 that was 
broken up in 2012. In 2012-2013 their R&D invest-
ment resumed to grow at significant pace but with 
a level of net sales practically unchanged. In 2014, 
the R&D level remained practically unchanged but 
with significant decrease of net sales. Over the last 
period, the R&D investment of the companies ba-
sed in the UK resumed to grow but along a strong 
decrease in net sales (as explained above, due to 
the fall in commodity prices). The average profita-
bility of the UK companies, like their French coun-
terparts, shows a high but decreasing trend in the 
period 2010-2014 that seems to be stabilised over 
2014-15.
4.3 | Performance of companies based in the 3 top EU Member States
FIGURE 4.1. ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE GERMAN COMPANIES.
Note 1: * Figures for 2015 for the whole sample of 217 German companies were 10.5% for R&D, 8.4 for net sales and 5.2% profitability. 
The diagram represents 124 companies for which R&D and net sales are available for the 10 years period.
Note 2: Profitability defined as the ratio of operating profits over net sales.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 4.2. ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE FRENCH COMPANIES.
Note1 : * Figures for 2015 for the whole sample of 117 French companies were 1.9% for R&D, -3.1% for net sales and 6.4% profitability. 
The diagram represents 74 companies for which R&D and net sales are available for the 10 years period.
Note 2: Profitability defined as the ratio of operating profits over net sales.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
FIGURE 4.3. ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE UK COMPANIES.
Note 1: * Figures for 2015 for the whole sample of 276 UK companies were 4.1% for R&D, -20.9 for net sales and 7.5% profitability. 
The diagram represents 112 companies for which R&D and net sales are available for the 10 years period.
Note 2: Profitability defined as the ratio of operating profits over net sales.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
4.4 | R&D intensity trends by companies based in selected Member States
In 2015/16, for the third consecutive year, the average R&D 
intensity of the EU-1000 companies increased because of 
the higher increase of R&D investments compared to that 
of net sales, 7.4% vs. -3.2% (see Figure 4.4). 
It is important to remember that a few large but low R&D 
intensity sectors have a big effect on some country average 
R&D intensities. One example is Oil & Gas Producers and 
Banks for the UK. In the 2015/16, these sectors contributed 
52.0% of the UK's Scoreboard company sales, so if these 
two sectors had been left out, the average R&D intensity of 
UK companies would have substantially increased.
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FIGURE 4.4. TRENDS IN R&D INTENSITIES FOR EU SCOREBOARD COMPANIES IN SELECTED MEMBER STATES.
Note: * Figures for 2015 for the current sample of EU 1000 companies from the respective countries and for previous years for samples of each Scoreboard.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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5 PERSISTENCE AND PATTERNS OF R&D GROWTH
69The 2016 EU Industrial R&D Scoreboard
Policymakers seeking to encourage companies to increase 
their R&D investments require a sound understanding of 
the realities of the dynamics of firm-level R&D investment. 
Improving our knowledge of growth processes of R&D in-
vestment can help to improve the effectiveness of policies 
aimed at stimulating R&D investment. This chapter descri-
bes the R&D growth paths of firms by presenting new evi-
dence from the Scoreboard dataset, and discusses some 
policy implications. 
The objective of this chapter is to provide a clear and co-
herent picture of the growth of R&D investment in compa-
nies, to have a better understanding of the broad features 
of the dynamics of R&D investment. To this end, we focus 
on the total R&D investment data, reported at the com-
pany level, for the Scoreboard companies, and track their 
R&D dynamics over time, for the period 2000-2014. Diffe-
rent quantitative techniques are used to highlight different 
facets of R&D investment dynamics.
Key findings
• Most firms have a positive but modest growth rate of 
R&D investment from one year to the next. However, 
in each year a handful of firms experience rapid grow-
th or decline of R&D.
• Focusing on a selection of large firms that experien-
ced rapid R&D growth, and identify the names and 
R&D growth rates of these ‘superstar’ performers. Ra-
pid R&D growth is not confined to certain industries: 
instead we see that these firms are observed in all 
sectors.
• We also investigate the time profiles of R&D invest-
ment over the last dozen years, for leading firms in 
selected sectors, using longitudinal company-level 
line-plots. These plots underline the heterogeneity of 
R&D paths, even for firms in the same sector. Some 
firms have rapid growth, alongside their rivals who 
may have stagnating R&D. For example, in the ICT 
services sector, Microsoft and Google boosted their 
R&D investment while Fujitsu experienced decline in 
R&D. Hence, not all firms in the same sector have the 
same R&D investment strategies.
5.1 | Introduction
A longitudinal dataset for Scoreboard companies was 
constructed by merging cross-sectional data for individual 
years, covering the period 2000-2014, although data co-
verage varies across years. This allowed us to track the 
evolution of key variables (in particular, R&D investment 
and total sales) for each company in the database. 
Annual growth rates of R&D investment are calculated in 
the usual way (Tornqvist et al., 1985)10 as follows: Growth 
rate of R&Dit = log(R&D)it – log(R&D)it-1 , for company i in 
year t. Amounts are converted into Euros for all companies, 
and statistics for R&D and sales are presented in millions 
of Euros (unless otherwise stated)11.
10 Tornqvist L., Vartia P., Vartia Y.O. (1985). How Should Relative Changes Be Measured? American Statistician 39(1), 43-46. 
11 Data cleaning involves focusing only on firms with positive sales, with R&D intensity less than 100%, and where R&D investment is non-missing and positive.
Persistence and Patterns of R&D Growth5
5.2 | Growth rates distribution
We begin our analysis by looking at the distribution of 
growth rates, to better appreciate the variation across 
companies in terms of the rates of R&D growth that they 
can achieve. Figure 5.1 below plots the growth rates dis-
tribution for the years 2014, 2013 and 2012. Instead of a 
normal or ‘Gaussian’ distribution, we observe a heavy-tai-
led ‘tent-shaped’ distribution, the form of which is stable 
across years. While most firms have positive but modest 
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12 In terms of log growth rates, the values are -0.0155 to 0.1887, with 10% of firms having an R&D growth rate of 0.3964 or more, and 1% having a growth rate of 1.1870 
or more.
FIGURE 5.1 - DISTRIBUTION OF GROWTH RATES OF R&D INVESTMENT, FOR RECENT YEARS.
Selection of large companies with rapid R&D growth
Table 5.1 below shows a selection of 34 companies that 
experience rapid growth of R&D investment in 2014. Inclu-
sion in the selection of firms in Table 5.1 requires that a 
firm have a relatively fast growth rate of R&D investment 
(log growth higher than 0.5) and with net sales in 2014 
greater than 1000, and with R&D investment in 2013 of 
at least 20 (to avoid emphasizing fast R&D growth that is 
due to starting from a low base level for R&D investment). 
R&D growth rates, a handful of firms have growth of R&D 
expenditure that is either very fast (for large positive values 
of the log growth rate) or that is large and negative, indica-
ting rapid decline (for large negative values of log growth 
rate). While most firms do not experience much change in 
R&D from year to year, a significant minority of rapid R&D 
growth firms have a disproportionately large effect on the 
overall R&D landscape. 
For the year 2014, the interquartile range (i.e. the 50% of 
observations that are in the centre) runs from -1.5% to 
+18.9%12. This indicates that most firms have mildly po-
sitive growth rates of R&D. Most firms in our sample tend 
to increase, rather than decrease, their R&D investments 
from one year to the next (although this is probably due 
to how firms are selected for inclusion in our Scoreboard 
sample). 10% of firms have an R&D growth rate of 48.6% 
or more, and 1% of firms have an R&D growth rate of 
228% or more.
Figure 5.1 shows that a handful of companies experience 
very fast growth of R&D from one year to the next. But what 
are the identities of the fastest-growing R&D companies? 
What are their names, their sectors of activity, their sizes? To 
investigate this, we present some details on the top growth 
companies.
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The following points are observed:
• Most firms hardly change their R&D investment from 
one year to the next.
• In each year, a handful of firms experience rapid decli-
ne in R&D or growth in R&D.
• These latter firms make a disproportionate contribution 
to industrial dynamics, because they are often large 
firms with a large, and rapidly growing, share of R&D.
• Firms experiencing rapid R&D growth rates are found 
in all sectors.
Table 5.1 (page 73 and 74) shows that some firms are 
able to increase their R&D investment remarkably quickly 
in the space of one year. But what about the longer-term 
performance of these companies? Are there any patterns 
in the longer-term growth profiles of R&D investment? Do 
firms in the same sector share the same trends in R&D 
investment? Which firms are growing and which firms are 
stagnating? 
To investigate these questions, we now take a sector-by-sec-
tor approach that provides a more detailed view on the time 
profiles of R&D investment. 
The companies are found in all sectors: whether they be 
high-tech sectors such as ICT services, ICT producers and 
Pharmaceuticals, or even relatively mature technology sec-
tors such as Services or Transport. The largest company (in 
terms of sales) from this selection of companies is Softbank 
Group, from the ICT services sector, whose R&D investment 
jumped up from 24m EUR in 2013 to 74m EUR in 2014. 
Tesla motors, and Tata motors, both from the ‘Automobiles 
and parts’ sector, also more than doubled their R&D invest-
ment during this period. Other well-known companies in this 
selection of fast-growing R&D investors include Lenovo and 
Facebook.
bvd company name country
net 
sales 
(€m)
sector group
r&d in 
2014 
(€m)
21r&d 
in 2013 
(€m)
r&d growth 
rate (%)
SOFTBANK GROUP CORP JP 59 195 ICT SERVICES 74 24 207.2%
LENOVO GROUP LIMITED HK 38 132 ICT PRODUCERS 958 581 65.1%
TATA MOTORS LIMITED IN 33 190 AUTOMOBILES & PARTS 2 346 1 123 108.9%
COMMONWEALTH BANK OF 
AUSTRALIA AU 15 666 SERVICES 370 211 75.3%
SHANGHAI CONSTRUCTION 
GROUP CO., LTD CN 14 879 OTHER 140 73 91.1%
THERMO FISHER SCIENTIFIC 
INC. US 13 911 HEALTH 569 326 74.7%
ALLERGAN PLC IE 10 759 PHARMACEUTICALS & BIOTECHNOLOGY 894 508 76.0%
FACEBOOK, INC. US 10 268 ICT SERVICES 2 196 1 165 88.4%
CHINA RAILWAY ERJU CO., LTD 
(CREC) CN 9 336 OTHERS 64 36 78.4%
CHINA GEZHOUBA GROUP CO., 
LTD CN 9 272 OTHERS 105 43 146.7%
BRF S.A. BR 8 997 OTHERS 60 21 181.1%
TABLE 5.1 - DETAILS ON A SELECTION OF 34 LARGE COMPANIES WHICH HAD THE FASTEST GROWTH RATES OF R&D INVESTMENT OVER 2013-2014.   
TABLE CONTINUES ON NEXT PAGE → 
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bvd company name country
net 
sales 
(€m)
sector group
r&d in 
2014 
(€m)
21r&d 
in 2013 
(€m)
r&d growth 
rate (%)
MAHINDRA & MAHINDRA 
LIMITED IN 8 306
AUTOMOBILES & 
PARTS 199 88 127.3%
BAIDU INC. CN 6 603 ICT SERVICES 940 553 69.9%
ISRAEL CORPORATION LIMITED IL 5 033 INDUSTRIALS 138 82 67.0%
BOE TECHNOLOGY GROUP 
CO., LTD CN 4 774
ELECTR. & ELECTRICAL 
EQUIPMENT 137 76 80.5%
ANHUI JIANGHUAI 
AUTOMOBILE CO., LTD CN 4 235
AUTOMOBILES & 
PARTS 340 164 107.0%
CHINA CSSC HOLDINGS 
LIMITED CN 3 703 INDUSTRIALS 103 53 94.1%
AVAGO TECHNOLOGIES 
LIMITED SG 3 516 ICT PRODUCERS 572 273 109.3%
GEELY AUTOMOBILE HOLDING 
LIMITED KY 2 926
AUTOMOBILES & 
PARTS 89 51 74.2%
TOFAS TÜRK OTOMOBIL 
FABRIKASI A.S. TR 2 640 
AUTOMOBILES & 
PARTS 148 39 274.9%
TESLA MOTORS US 2 634 AUTOMOBILES & PARTS 383 191 100.3%
SHENZHEN O-FILM TECH 
COMPANY LIMITED CN 2 586
ELECTR. & ELECTRICAL 
EQUIPMENT 115 65 76.8%
INTERCONTINENTAL 
EXCHANGE, INC US 2 547 SERVICES 64 37 73.3%
DMG MORI AG DE 2 229 INDUSTRIALS 91 52 76.1%
CHINA ZHONGWANG HOLDINGS 
LIMITED KY 2 150 INDUSTRIALS 44 24 81.2%
CHINA LESSO GROUP HOLDING 
LIMITED KY 1 995 INDUSTRIALS 62 33 87.3%
YINGLI GREEN ENERGY 
HOLDING COMPANY LIMITED KY 1 740
ELECTR. & ELECTRICAL  
EQUIPMENT 76 39 94.0%
GOERTEK INCORPORATED 
COMPANY CN 1 670
ELECTR. & ELECTRICAL  
EQUIPMENT 104 62 69.2%
SCIENTIFIC GAMES CORP US 1 471 TRANSPORT 136 53 158.1%
ZEBRA TECHNOLOGIES CORP US 1 376 ELECTR. & ELECTRICAL  EQUIPMENT 124 75 65.8%
GOPRO, INC US 1 148 OTHERS 125 61 105.9%
MITAC HOLDING CORPORATION TW 1 093 ICT PRODUCERS 75 21 256.4%
N BROWN GROUP PLC GB 1 070 OTHERS 62 22 184.0%
HANERGY THIN FILM POWER 
GROUP LIMITED BM 1 021 ALTERNATIVE ENERGY 55 21 163.5%
TABLE 5.1 - DETAILS ON A SELECTION OF 34 LARGE COMPANIES WHICH HAD THE FASTEST GROWTH RATES OF R&D INVESTMENT OVER 2013-2014. 
Note: Selection criteria: we include only firms with a relatively fast growth rate of R&D (log growth higher than 0.5), with net sales in 2014 of more than 1000, and with R&D invest-
ment in the base year of at least 20. Growth rates g in the last column calculated as g = [R&D(2014)-R&D(2013)]/R&D(2013). Sales and R&D are expressed in million of Euros.
Source: The 2016 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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5.3 | R&D trajectories of the largest R&D investors in specific sectors
In what follows, we consider the R&D trajectories of the largest investors in specific sectors13. 
13 Sectors are defined in a rather broad way, following a typical classification applied in the Scoreboard.
Automobiles and parts sector
Figure 5.4 below shows that Volkswagen has invested hea-
vily in R&D since around 2010, while its competitors in the 
automobiles & parts industry have increased their R&D in-
vestments only gradually (Robert Bosch, BMW) or else have 
stagnated (GM, Ford, Daimler). 
Our focus on the world’s largest R&D investors (sorted ac-
cording to R&D investment in the year 2014) makes us 
potentially vulnerable to sample selection bias, because 
firms with stagnating or declining R&D are likely to exit the 
dataset and hence be excluded from the analysis. Despite 
this possible bias, however, we still find much heterogenei-
ty in growth paths, with fast-R&D-growth firms operating 
alongside stagnating or declining R&D investors. Without 
this sample selection bias, we would expect to find even 
more firms experiencing rapid decline in R&D investments. 
R&D investment of some firms seems to have suffered 
from the 2008 financial crisis (in particular, Toyota, GM, and 
Ford). For other firms, however, the financial crisis does not 
appear to strongly interrupt the trend of stagnating R&D 
investment levels. Our results do not suggest that the 2008 
financial crisis, by itself, is to blame for stagnating R&D 
levels. The crisis may have hit some companies relatively 
hard (e.g. US companies), but these firms have also recove-
red to some extent.
FIGURE 5.4 - LINE PLOT OF R&D INVESTMENT OVER TIME, BY COMPANY, FOR THE LARGEST R&D INVESTING COMPANIES IN THE “AUTOMOBILES AND PARTS” SECTOR. 
Note : Firms sorted by R&D investment in 2014, in billions of Euros.
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Electronic and Electrical Equipment sector
Figure 5.5 vividly illustrates how R&D growth in the “Elec-
tronics and Electrical equipment” industry has been domi-
nated by Samsung. Similarly to the case of Volkswagen 
among automobile companies, Samsung’s meteoric in-
creases in R&D investing have set it apart from its rivals, 
perhaps because Samsung has exploited opportunities in 
the emerging smartphone sector. Hon Hai, Danaher, and 
Schneider have steadily increased their R&D investments 
(although starting from a low base): the R&D investment 
of Danaher has increased tenfold over the period 2000-
2014, and Hon Hai has had even faster growth of R&D 
investment (from 0.06m EUR in 2001 to 1.27m EUR in 
2014). Other firms, such as Siemens and Hitachi, experien-
ced stagnating R&D levels. Again, it is not always the case 
that the 2008 financial crisis interrupts any previous trend 
in R&D investment. Instead, companies have considerable 
heterogeneity in their R&D investment dynamics, even if 
they are within the same sector.
FIGURE 5.5 - R&D INVESTMENT OVER TIME, BY COMPANY, FOR THE LARGEST R&D INVESTING COMPANIES IN THE 
“ELECTRONIC AND ELECTRICAL EQUIPMENT” SECTOR.
Note : Firms sorted by R&D investment in 2014, in billions of Euros.
ICT producers sector14
14 Comprising companies which are also engaged in the ICT services sector, e.g. Apple.
We now turn to the ICT producers sector (see Figure 5.6). 
Intel, Apple, Qualcomm and EMC all increased their R&D 
investments, while some other firms had a bumpier ride. 
In Europe, Alcatel-Lucent, Nokia and Ericsson have had 
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stagnating R&D investment levels in the recent decade 
(Alcatel-Lucent has been recently merged with Nokia). 
These changes don’t appear to be entirely attributable to 
the financial crisis – note that Alcatel and Nokia actually 
seem to have increased their R&D investments at the 
time of the 2008 crisis. Apple’s smooth increase in R&D 
investment appears to be particularly unaffected by the 
onset of the financial crisis. 
FIGURE 5.6 - R&D INVESTMENT OVER TIME, BY COMPANY, FOR THE LARGEST R&D INVESTING COMPANIES IN THE “ICT PRODUCERS” SECTOR.
Note : Firms sorted by R&D investment in 2014, in billions of Euros.
ICT services sector
Figure 5.7 shows that several companies in the ICT servi-
ces sector have had a bullish growth of R&D investments: 
in particular Microsoft, Google and Oracle. Meanwhile 
Japanese company Fujitsu experienced a decline, while 
SAP and IBM had more mediocre R&D investment per-
formances. Baidu, the Chinese web services company, 
which appeared in our selection of fast-growing R&D 
investors in Table 1, experienced a prolonged growth in 
R&D investment, from 0.002m EUR in 2004 to 0.94m 
EUR in 2014.
76 The 2016 EU Industrial R&D Scoreboard
FIGURE 5.7 - R&D INVESTMENT OVER TIME, BY COMPANY, FOR THE LARGEST R&D INVESTING COMPANIES IN THE “ICT SERVICES” SECTOR.
Note : Firms sorted by R&D investment in 2014, in billions of Euros.
Pharmaceuticals and Biotechnology sector
Pharmaceutical companies also had mixed experiences 
regarding the evolution of their R&D investments (Figure 8). 
Novartis, Roche, and Johnson and Johnson had the most 
impressive growth of R&D. Meanwhile, Pfizer, Merck and Sanofi 
have struggled to maintain a stable level of R&D investment. 
The avid reader will have noticed that the 9 largest R&D 
investors in the “Pharmaceuticals and Biotechnology” 
sector are all Pharmaceuticals (rather than Biotech) 
companies. In unreported analysis, we distinguish between 
pharmaceuticals and biotechnology by focusing only on 
the 9 largest biotech R&D investors. 
Among biotech companies, R&D investment seems to be 
experiencing steady growth overall, although starting from 
a relatively low initial level.
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FIGURE 5.8 - R&D INVESTMENT OVER TIME, BY COMPANY, FOR THE LARGEST R&D INVESTING COMPANIES IN THE “PHARMACEUTICALS AND 
BIOTECHNOLOGY” SECTOR.
Note : Firms sorted by R&D investment in 2014, in billions of Euros.
The following points are observed:
• Firms in the same sector can have very different 
patterns of R&D investment. Some may have sus-
tained growth while others may have sustained 
stagnation
• The financial crisis, per se, does not always seem to 
have strongly affected the R&D investment trends 
in all firms. Some firms appear conspicuously una-
ffected.
• Firms R&D trends appear to have reacted differently to 
the financial crisis.
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6 DISTRIBUTION OF INDUSTRIAL R&D ACROSS BORDERS
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However, companies make their decision on the location of 
R&D and production activities based on their market strate-
gies, their need to optimize costs or for fiscal purposes. This 
has important policy implications and affects the analysis of 
economic and R&D trends of companies aggregated by coun-
try and region. 
In this chapter, we present the results of an exercise which 
aims to improve our analysis of the location of companies' 
innovation activities. The location of innovation activities 
is estimated from the patent portfolio of the Scoreboard 
companies15. The actual location of innovation activities 
is proxied by the location of the inventors as reported in 
patent documents. R&D investments are then assigned to 
different countries/regions according to the share of patents 
from inventors residing in the specific area considered.
The analysis is carried out using the sample of top 2000 
R&D investors worldwide as reported in the 2014 edition of 
the Scoreboard.
15 The patents filed by these companies at the European Patent Office (EPO) and the US Patent Office (USPTO) over the period 2011-2013 have been retrieved from the PATS-
TAT database. The matching has been carried out on a by-country basis using a series of string matching algorithms contained in the Imalinker system (Idener Multi Algorithm 
Linker) developed IDENER (Seville). The matching results have been improved using the PATSTAT standardized name as provided by ECOOM (K.U. LEUVEN).
Key findings
• On average, companies located in the EU allocate 1/4 
of their R&D investments outside the EU.
• The EU-US R&D flows are the largest R&D intraregio-
nal flows. UK is the EU member state with the highest 
outward R&D, while Switzerland is the second most 
important source of EU inward R&D. 
• "Health Industries" show the highest volumes of 
inward and outward flows, while "Automobiles" are 
those with the lowest ones.
• Merck US, Novartis, Roche, General Motors and Intel 
are the non-EU based companies which invest more 
in the EU. For all these companies, the estimated R&D 
investment in EU is over 1 billion €.
Distribution of Industrial R&D Across Borders6
Knowing the actual geographical distribution of companies' R&D activities across the 
globe is key to design effective R&I policies which can maximize their intended territo-
rial impact. In the Scoreboard, normally companies are allocated to the countries where 
they have their headquarters (HQ). 
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→ The industrial classification used 
is an aggregate of ICB sectors fo-
cusing on the most innovative ma-
nufacturing and services industries:
 
ICT producers: Computer Hardware; Elec-
tronic Office Equipment; Semiconductors; 
Telecommunications Equipment; Electronic 
& Electrical Equipment.
Health industries: Pharmaceuticals; Heal-
th-biotechnology; Health care equipment & 
services.
ICT services: Computer Services; Internet; 
Software & Computer Services; Fixed Line Tele-
communications; Mobile Telecommunications.
Automobiles: Automobiles; Auto Parts.
Industrials: General Industrials; Industrial 
Engineering, Industrial Metals & Mining, In-
dustrial Transportation.
Aerospace & Defence: Aerospace; Defence.
Chemicals: Chemicals.
Other sectors: Leisure Goods; Oil & Gas 
Producers; Banks and Financial Services; 
Construction & Materials; Food producers; 
etc.
 
→ From a territorial viewpoint, 
R&D activity in a geographical 
area can be funded by local com-
panies (home), which can also fund 
R&D in other geographical areas 
(outward), or by foreign affiliated 
companies (inward). 
6.1 | Patent analysis to assess companies' major innovation location
This section shows the extent to which R&D investments 
of the Scoreboard companies flow between the EU and 
other economic areas. In the Scoreboard 2015 edition, 
a subchapter focused on the internationalization of the 
patenting activities of the Scoreboard companies16. Here 
we extend the methodology in order to estimate R&D flows 
across different economic areas by weighting patent data 
which have been fractionally counted based on inventors 
location information with R&D investments. 
In other words, for each company R&D is allocated to 
different world regions based on the number of patents 
invented in that region, for this reason we invite the reader 
to interpret the results with caution. 
The total amount of R&D invested in the EU from EU 
based Scoreboard companies is slightly over 112 billion €. 
These companies also invested almost 40 billion € in other 
geographical areas. The inflow of R&D investments from 
other geographical areas to the EU was approximately the 
same. R&D flows from the EU to the other economic areas 
and viceversa appears to be in balance
Figure 6.1 illustrates the R&D flows of EU companies toward 
external countries and EU R&D inflows from companies 
located in other countries. The R&D flows between EU and 
US are by far the largest ones. About 62% of EU outward 
R&D goes to the USA; at the same time the R&D inflows 
from the US represent 62% of the total EU inward R&D.
16 See the " The 2015 EU Industrial R&D Investment Scoreboard"
Box 6.1 -  
Key concept used in this chapter
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FIGURE 6.1 – R&D FLOWS FROM AND TOWARDS EU. 
Other European countries (mainly Switzerland) contribute 
about 20% of the total EU inward R&D. Other economic 
areas (Rest of the World) contribute the remaining 18% of 
EU inward R&D. In particular, R&D outward flows from EU to 
China and Japan are greater than the corresponding inflows. 
In the following sections we explore these flows in more detail.
6.2 | How different sectors contribute to the R&D in-out-ward flows?
In the previous section, we saw that the estimated R&D 
flows from EU (outward) and to EU (inward) are balanced 
and that the highest R&D flows from and to the EU come 
from USA. Here we take a closer look to the extent to 
which different industrial sectors contribute to this overall 
picture. 
Table 6.1, reports the inward and outward flows of R&D 
investment in and from EU. As explained in Box 6.1 “home” 
refers to the amount of R&D that has been invested from 
EU based companies within the EU while “outward” is the 
amount of R&D which was directed from EU companies 
to other countries/world regions. Finally “inward” R&D 
corresponds to investments in the EU coming from non 
EU based companies. The difference between inward and 
outward flows gives the R&D net balance for the EU. This 
figure can be disaggregated to show the "EU position" with 
respect to the rest of Europe and the rest of the world.
US
JP
CN
EU
24.4
7.9
0.3
2.824.6
1.7
4.3
2.4
RoW
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TABLE 6.1 – ESTIMATED INWARD AND OUTWARD R&D FLOWS FOR EU BY SECTOR (€M). 
EU based firms active in the “Automobiles” sector have 
invested more than thirty billion € within the Union followed 
by “Health Industries” (19,614 millions) and “ICT producers” 
(16,587 millions). Among these three industries the "Health 
Industries" show the highest volumes of inward and outward 
flows. Taken together, these are higher than the R&D invested 
at home by EU companies and give rise to a positive net 
balance. The positive balance is given by the high R&D 
inflows from other European countries (mainly Switzerland). 
In the “Other sectors” the EU shows a significant R&D deficit 
(which represent 32% of the home R&D investments). 
Overall, the slightly negative balance of the EU is mostly 
due to its position with respect to the "Rest of the world" and 
to a lesser extent to the US and it is almost compensated by 
the positive inward R&D from the rest of Europe. 
The internationalisation of R&D activities can be defined as 
the sum of the inward and outward R&D investment over 
the R&D spending within the EU. Following this definition 
the “Health Industries”, "Other sectors" and “ICT Producers” 
appears to be the most internationalised ones. In the "Health 
Industries" the sum of inward and outward flows outweigh 
the R&D invested within Europe, while in the "Other sectors" 
and “ICT Producers” it is around 90%. On the other side of 
the spectrum the "Automobiles" is the least internationalised 
sectors with a share of about 28%.
6.3 | Which EU companies are investing more abroad? 
In this paragraph we explore the extent to which Scoreboard 
companies present heterogeneous profiles with respect to 
the recourse to external markets for their R&D investments. 
The focus in this section is at the firm level and we look 
at the 6 companies with the highest R&D investments 
outside the EU from each one of the main sectors presented 
previously. For these companies we report in table 6.2 the 
R&D investments performed in EU and the flows towards 
other European countries, towards US and towards the 
rest of the world. The share of outward R&D flows over the 
total R&D investment of each firm is also calculated. For 
each sector companies are ordered according to the total 
estimated R&D outflow. 
GlaxoSmithKline, Astrazeneca and Robert Bosch are 
the companies with the highest R&D outflows from 
the EU; but while flows from the first two are mainly 
directed to the US, Bosch seems to be much more 
oriented towards the rest of the world. Companies in 
the ICT and financial services (e.g. Vivendi or HSBC) 
present very high outflows compared to their overall 
R&D investments17. 
17 However, these results should be interpreted with caution because they are probably affected by the different policies of intellectual property offices with respect to software 
related patent. This type of patent cannot be filed at the EPO but are accepted at the USPTO. As a result, using patents for weighting R&D expenditure in that cases may lead 
to an overestimation of the R&D performed in the USA.
sector
eu-28 r&d flows eu r&d net balance
HOME OUTWARD (0) INWARD (I)
By geographical areas
TOTAL (I-O) REST OF EUROPE USA
REST OF THE 
WORLD
Aerospace & Defence 7 616 1 514 1 661 146 -29 83 93
Automobiles 33 071 5 135 4 271 -918 -125 455 - 1 248
Chemical 3 630 1 136 1 541 405 305 61 39
Health Industries 19 614 10 036 13 507 3 471 4 436 -349 - 616
ICT Producers 16 587 7 127 7 439 312 149 1 082 -919
ICT Services 7 266 2 007 2 914 908 30 1 411 -534
Industrials 9 984 3 956 3 959 3 787 -98 -686
Other Sectors 14 272 8 744 4 194 -4 551 643 -2 911 -2 283
Total 112 040 39 656 39 432 -224 6 196 - 268 -6 152
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TABLE 6.2 - INTERNATIONAL R&D ACTIVITIES OF EU-28 COMPANIES.
(the 5 companies with the highest estimated R&D outflows are reported for each sector)
Source: Authors’ own calculations on EPO-USPTO patent families.
company sector country
r&d flows
share of 
outflowseu rest of europe usa
rest of the 
world
AIRBUS
Aerospace & 
Defence
NL 2 726 3 69 689 21.8
ROLLS-ROYCE GB 528 12 143 16 24.4
ZODIAC AEROSPACE FR 97 1 107 16 56.0
FINMECCANICA IT 1 728 96 16 6.1
MEGGITT GB 33 27 45 11 71.8
ROBERT BOSCH
Automobiles
DE 2 298 57 328 1 923 50.1
DELPHI GB 309 416 170 65.5
FIAT IT 2 402 7 461 74 18.4
DAIMLER DE 5 042 14 166 327 9.1
CONTINENTAL DE 1 585 2 173 53 12.6
BASF
Chemical
DE 1 333 60 256 97 23.7
DSM NL 270 94 53 14 37.5
AKZO NOBEL NL 203 9 109 26 41.3
SOLVAY BE 175 1 44 22 27.5
EVONIK INDUSTRIES DE 317 4 38 15 15.2
GLAXOSMITHKLINE
Health 
Industries
GB 2 056 24 1 819 383 52.0
ASTRAZENECA GB 1 547 16 1 588 133 52.9
SANOFI-AVENTIS FR 3 839 35 850 97 20.4
BAYER DE 2 386 24 604 148 24.5
MERCK DE DE 772 26 564 150 48.9
ALCATEL-LUCENT
ICT Producers
FR 1 202 5 797 437 50.8
NOKIA FI 2 995 25 589 569 28.3
ERICSSON SE  2 622 9 425 547 27.2
SIEMENS DE 3 674 68 582 144 17.8
SEAGATE TECHNOLOGY 
TECHNOLOGY IE 23 0 658 132 97.8
SAP
ICT Services
DE 1 342 13 378 425 37.8
SAGE GB 16 171 91.3
DASSAULT SYSTEMS FR 227 115 16 36.6
SQUARE ENIX GB 12 3 119 90.9
YANDEX NL 2 4 99 98.0
VOLVO
Industrials
SE 1 411 1 188 528 33.7
CNH INDUSTRIAL NL 248 10 453 146 71.1
PHILIPS NL 1 324 42 376 82 27.4
ALSTOM FR 500 357 104 24 49.2
HEXAGON SE 73 127 35 15 70.9
ROYAL BANK OF SCOTLAND
Other
GB 371 4 637 129 67.4
VIVENDI FR 111 7 641 85.4
HSBC GB 73 6 441 115 88.5
ROYAL DUTCH SHELL GB 416 2 406 84 54.2
UNILEVER NL 626 3 103 285 38.5
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6.4 | Which non-EU companies are investing more in the EU? 
Complementary to what was previously presented, it 
is interesting to look at the R&D invested in the EU 
by Scoreboard companies based elsewhere (in other 
European countries or in the rest of the world). To this 
aim we look at the 5 "foreign" companies with the 
highest estimated R&D investments in the EU. Also in 
this case, we report in table 6.3 the R&D investments 
performed in EU, in other European countries and in 
the rest of the world. However, now the focus is on 
the EU column, which in this case represents the flow 
or R&D investment towards EU and is used to order 
companies. 
Also in this case the companies with the highest R&D 
flows are operating in the "Health Industries". Merck US, 
NOVARTIS and ROCHE, one based in the US and the other 
two in Switzerland, have each invested more than 2 billion 
€ R&D in the EU. 
In general, the share of R&D towards EU from companies 
in "ICT Producers" is higher than that of companies in the 
"ICT Services". With about 1 billion €, Intel is the company 
operating in the ICT related industries with the highest R&D 
investments in the EU, followed by CISCO System. Among 
the firms in the "ICT Services", Microsoft and IBM show the 
highest R&D investments in the EU. 
In the “Aerospace and Defence” sector, the Canadian 
BOMBARDIER shows very high R&D investments in the EU, 
both in terms of volume and share (74%). This surprising 
result can be due to the activities of Bombardier in the 
transportation industry. A higher patent propensity in the 
transport sector than in the Aerospace could lead to biases 
in our analysis. In order to improve our methodology, 
we are currently looking into ways to estimate the cost 
related to the development of different technologies using 
Scoreboard companies.
In general there is high variance of outflows shares 
also within sectors. For example MEGGITT and ZODIAC 
Aerospace, which operate in the “Aerospace and Defence” 
sector, show very high shares of R&D outflows; close or 
over 50%. In the chemical sector, the five companies 
reported present the most similar R&D outflows shares. 
In the “Automobiles” sector DELPHI (which started off as 
the parts arm of GM) shows a share or R&D outflows close 
to 66%; this high outflow share correspond to a volume of 
outward R&D spending close to Daimler. 
Finally, among the 40 companies listed in the table, 10 
are based in the UK, 9 in Germany, 7 in the Netherlands 
and 6 in France. With about 7 billion € of total outward 
R&D UK ranks first when considering investments abroad, 
followed by Germany (~6.6), France (~3.6) and the 
Netherlands (~2.7). 
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TABLE 6.3 - R&D ACTIVITIES OF EXTERNAL COMPANIES IN EU-28. (Note: the 5 companies with the highest estimated R&D inflows are reported for each sector) 
Source: Authors’ own calculations on EPO-USPTO patent families.
company sector country
r&d flows
share of 
outflowseu rest of europe usa
rest of the 
world
BOMBARDIER
Aerospace & 
Defence
CA 878 52 46 216 73.8
UNITED TECHNOLOGIES US 301 6 1 183 192 17.9
TEXTRON US 97 310 18 22.8
BOEING US 83 1 2 150 25 3.7
GENERAL DYNAMICS US 61 1 182 11 23.8
GENERAL MOTORS
Automobiles
US 1 051 1 4 095 338 19.2
TATA MOTORS IN 935 1 29 32 93.8
FORD MOTOR US 579 64 3 375 138 13.9
NISSAN MOTOR JP 197 36 2 977 6.1
AUTOLIV US 181 1 72 81 53.9
SYNGENTA
Chemical
CH 193 376 258 82 21.2
DUPONT US 157 25 1 133 177 10.5
DOW CHEMICAL US 131 13 997 91 10.7
CLARIANT CH 128 4 8 9 85.9
MONSANTO US 119 884 70 11.1
MERCK US
Health 
Industries
US 2 346 82 2 596 514 42.4
NOVARTIS CH 2 269 1 152 3 151 284 33.1
ROCHE CH 2 215 1 259 2 790 581 32.4
JOHNSON & JOHNSON US 949 382 3 827 497 16.8
PFIZER US 885 5 4 290 217 16.4
INTEL
ICT Producers
US 1 008 16 4 835 1 176 14.3
CISCO SYSTEMS US 711 207 2 753 613 16.6
BROADCOM US 377 4 1 071 188 23.0
CANON JP 257 46 745 1 042 12.3
HEWLETT-PACKARD US 243 2 1 450 670 10.3
MICROSOFT
ICT Services
US 521 27 6 696 395 6.8
IMB US 466 146 2 190 1 203 11.6
GOOGLE US 302 131 3 927 392 6.4
ORACLE US 195 78 2 841 397 5.6
MENTOR GRAPHICS US 117 109 9 49.6
ABB
Industrials
CH 578 240 197 76 52.9
GENERAL ELECTRIC US 562 28 2 311 447 16.8
LIEBHERR-INTERNATIONAL CH 416 32 8 91.0
CATERPILLAR US 239 5 1 281 121 14.5
DEERE US 163 812 25 16.3
PROCTER & GAMBLE
Others
US 492 7 897 73 33.5
NESTLE CH 301 589 353 74 22.9
SCHLUMBERGER US 246 52 397 130 29.8
SONY JP 241 2 199 2 711 7.6
DNB NO 214 100.00
In the “Automobiles” sector GENERAL MOTORS (which own 
between others OPEL in Germany and Vauxhall in the UK) 
shows a high volume of R&D toward the EU (about 1 billion 
€). It is closely followed by TATA (which acquired Jaguar/
Land Rover) and FORD. As already discussed before, the 
main source of EU inward R&D are US based companies, 
followed by companies based in Switzerland (about 7.4 
billion €) and in Japan (~2.8).
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7 IMPACT OF CROSS-BORDER MERGERS AND  
ACQUISITIONS 
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This chapter analyses the geographical and sectoral 
trends of mergers and acquisitions (M&A) activities of the 
Scoreboard companies. The descriptive analysis is aimed 
to shed light on whether there is a transfer of ownership 
and control from non-European firms to European firms 
or viceversa. Using information on targets and acquirors’ 
sector of activity, the descriptive analysis provides facts 
and figures on the volumes of M&A agreements by 
market and technological similarities between targets 
and acquirors. 
The chapter concludes with the analysis on the 
relationship between the age of target firms and the 
performance of Scoreboard companies to determine 
what is the contribution of M&A to the growth of top R&D 
companies.
Key findings
• Companies based in the EU and the US are the main
actors of both national and cross-border M&A. Consi-
dering the total value of the M&A deals, the US is a net
target country, while the EU is a net acquiror.
• France, Germany and UK are the most targeted Euro-
pean countries and firms based in the US are the most
active acquirors of European firms in general.
• 60% of M&A deals involve firms operating in diffe-
rent product markets. However, 59% of the total
investments in M&A goes to technological related
activities.
• The number of acquisitions seems to decline with
the increase of the average age of the targeted
companies.
7.1 | Introduction
Cross-border M&A are defined as M&A that involve an 
acquiror firm and a target firm whose headquarters are 
located in different countries. This type of investment 
constitutes one of the main forms of foreign direct 
investment and its effects on host economies are at the 
centre of the policy debate. On the one hand, they have 
become a major channel for reorganizing R&D activities 
both domestically and internationally, since they enable 
firms to quickly acquire technology from external sources 
and expand their knowledge base by accessing new 
technological assets. On the other hand, M&A activities 
may lead to important changes in the industry structure 
and concentration, and host countries’ governments are 
concerned with their potential adverse effects and with the 
transfer of ownership to foreign hands. Examples of these 
vertical and horizontal industrial concentrations are given 
by M&A among Scoreboard companies: Rolls-Royce buying 
Germany-based Tognum (electrical components) for over 
€3bn, or Denali Intermediate (a company in computers and 
electrical components) buying Dell for € 24bn.
The data set on M&A deals is constructed using information 
from the Zephyr database of Bureau van Dijk. Specifically, 
the data include all the acquisitions of majority stakes 
(at least 50% of ownership) on both acquiror and target 
country and sector. 
The data collected consists of all the acquisitions made 
by the companies included in the 2013 Scoreboard over 
the period 2003-201218. A total of 8,370 deals for a 
total value €2624bn were reported. Figure 7.1 reports 
the total number and total value of these deals over 
time19, showing the cyclical nature of M&A. Economic 
expansion, regulatory changes and the emergence of new 
technologies influence the volumes of M&A deals, which 
follow a succession of high (2006) and low points (2009, 
end of financial crisis).
In addition, the value of M&A deals is highly skewed: the 
median value of a deal is €75m, the mean value is €600m 
and the standard deviation is €2.7bn.
7 Impact of cross-border mergers and acquisitions
18 The sample of M&As includes 1,566 different Scoreboard acquirors. Therefore, most of the Scoreboard acquirors engage in multiple acquisitions. 
19 Data on deal value is available for around half of the M&A deals.
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FIGURE 7.1 - NUMBER AND VALUE OF M&A DEALS. 
7.2 | Trends in geographical distribution of M&A
Figure 7.2 shows that the majority of the M&A deals involve 
companies based in the EU and the US both as acquirors 
and targets. US appear to be a net acquiring country, 
while Europe is both an active acquiring and targeted 
region. However, about 62% of total M&A involves firms 
located in the same geographical area (national M&A). In 
particular, 30.5% of the deals in the sample are within US 
firms, while 21% are within EU firms. Cross-border M&A 
represent 38% of all deals in the sample.
Looking at the total value of M&A deals in these two 
economic regions, the total value of the deals that 
targeted US companies was larger than the total US M&A 
investment. This situation is reversed for the EU.
FIGURE 7.2 - NUMBER AND VALUE OF M&A BY GEOGRAPHICAL AREAS.
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FIGURE 7.3 - TOP EU COUNTRIES IN M&A ACTIVITIES. 
Figure 7.3 reports the total number and values of M&A 
deals in the top European countries. UK, Germany and 
France are the most active acquiror countries in M&A. 
Differently from Germany and France, UK is a net target 
country.
About 50% of M&A deals (and 43% in terms of their 
value) involve firms located in different countries (i.e., 
cross-border M&A). Figure 7.4 reports the number and 
value of cross-border M&A investment undertaken by 
Scoreboard companies based in the EU. While the number 
of deals follow a similar trend to the total number of 
deals in Figure 7.1, the total value exhibit a peak in 2009, 
at the end of the financial crisis, to then drop dramatically 
in 2010 due to recession. 
Non-EU cross-border M&As with a EU target represent 
around 26% of the total number of cross-border M&As, 
but their share in total value is significantly smaller 
(around 16.5% of the total value of cross-border M&As). 
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Figure 7.5 shows that the value of non-EU acquisitions made 
by European firms exceeds the value of acquisitions made by 
non-European firms within the EU. France, Germany and United 
Kingdom are the most targeted European countries by non-
European Scoreboard firms. While, US Scoreboard firms are the 
most active acquirers of European firms (see Figure 7.6).
FIGURE 7.5 - CROSS-BORDER M&A (EU TARGETS AND ACQUIRORS).
FIGURE 7.6 - TOP 10 EU TARGET COUNTRIES BY ACQUIRORS’ GEOGRAPHICAL AREAS.
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7.3 | Trends in sectoral distribution of M&A
Figure 7.7 shows that M&A is concentrated in knowledge 
intensive service (KIS) sectors, and high tech and 
medium-high tech manufacturing. Scoreboard companies 
mainly acquire targets in these sectors, and most of the 
Scoreboard acquirors belong to these sectors.
A significant number of M&A occur within the same sector, 
and in particular, within medium-high tech manufacturing 
sectors, and high tech manufacturing sectors.
FIGURE 7.7 - M&A DEALS BY SECTOR GROUP.
Firms can enter new technology markets by targeting 
firms that are operating in different technologies. In this 
regard, technological related M&A activities are those 
deals between firms within the same sector20. 
The majority (53% in number of deals and 66% in value) 
of deals are between technologically related sectors and 
occur within medium-high R&D intensity sectors. 
Scoreboard companies mainly acquire targets in sectors 
with high and medium-high R&D intensity (around 67% of 
the deals). More in detail, Table 7.1 shows that Computer, 
electronic and optical products and other manufacturing 
(manufacturing of jewellery, music instruments, medical 
supplies, etc.) are the most targeted high and medium-
high R&D intensity sectors, representing around 66% of 
the deals from high-tech Scoreboard companies.
20 This variable places firms in a certain technology space rather than measures direct technological linkages between them. As pointed out in the literature review, technologi-
cal relatedness is mainly constructed using patent information from the target and the acquirer. Unfortunately, we do not have data on patent applications.
TABLE 7.1 - CROSS-TABULATION OF M&A IN HIGH R&D INTENSIVE SECTORS.
(nace r.2) sector
r&d intensity of acquiror sector
HIGH MEDIUM-HIGH MEDIUM-LOW
Computer, electronic and optical products 245 116 45
Other manufacturing 154 60 11
Wholesale trade 49 44 7
Computer programming, consultancy and related activities 39 53 18
Manufacture of other transport equipment 30 10 3
Telecommunications 28 30 54
Manufacture of machinery and equipment 18 3 3
Human health activities 14 15 6
Others 26 81 11
Total 603 412 158
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Finally, Figure 7.8 reports the time trend of both 
technological- and non-technological-related M&A, to 
understand the extent to which Scoreboard firms invest in 
other product markets that are more or less complementary 
with theirs. Deals are grouped according to whether acquirors 
and targets compete in the same product market or not. In 
practice, (product) market related M&A are deals between 
firms within the same 4-digit NACE sectors. 
Around 60% of M&A deals involve firms operating in 
different product markets (non-market related deals). 
In this respect, M&A may be seen as an instrument for 
product market diversification. However, 59% of the total 
investments in M&A goes to technological related activities.
FIGURE 7.8 - NUMBER AND VALUE OF TECHNOLOGICAL RELATED M&A.
7.4 | Age and performance of acquiring firms
This section provides a descriptive analysis of the 
relationship between the age of target firms and the 
performance of Scoreboard companies.
The sample on M&A deals is therefore completed with 
quantitative information of the targets collected from 
the Orbis database of Bureau van Dijk. In particular, we 
retain information on R&D investments, turnover and 
number of employees. As performance measures, we 
use labour productivity (turnover per employee), R&D 
intensity (R&D investment/turnover) and respective 
growth rates. In addition, the target’s age is approximated 
by the number of years from the date of incorporation to 
2013. After dropping all observations for which some of 
this data is missing, the remaining sample contains 2674 
M&A deals involving Scoreboard acquirors for the period 
2003-2012.
The average age of target firms is 20.5 years. Figure 
9 shows the average age of target firms by NACE rev. 
2 sectors and the numbers of observations (deals). 
Targets in ICT, R&D and computer and electronics are the 
youngest, while firms in metal products, machinery and 
equipment are the oldest. The trend of the number of 
acquisitions seems to decline with the average age of 
the targets.
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FIGURE 7.9 - AGE AND NUMBER OF TARGETS BY SECTOR GROUP.
To observe the relationship between acquirors 
performance and age of the targets, we divide the age 
into three age groups, using the 25th and 75th percentiles 
cut-off values (13 and 30 years, respectively).
Table 2 reports the average R&D intensity, labour 
productivity levels and growth rates, together with 
the growth rates of employment and net sales of the 
Scoreboard companies by categories of targets' age.
TABLE 7.2 - SCOREBOARD COMPANIES PERFORMANCE BY AGE GROUP.
Except for R&D intensity and R&D growth, companies 
acquiring younger targets are more productive and grow 
faster than those companies that acquire medium and 
mature targets, with employment and net sales growth 
rates circa twice as large. 
Firms acquiring medium old firms (with an age between 
14 and 30 years) have the highest R&D growth, but the 
lowest (negative) productivity, turnover employment 
growth rates.
Figure 7.10 shows the percentage of acquisitions and related 
deals by age group of the targets and by acquirors’ region. US 
and EU28 have the largest shares of deals (the total number 
of deals per age group is reported in parentheses next to 
the legend). However, the situations for EU28 and US appear 
to be reversed. US Scoreboard firms acquire a considerable 
larger share of young and medium-old firms (41%), and 
fewer mature firms (28%). EU28 Scoreboard acquirers, on 
the other hand, have a different M&A strategy, acquiring a 
similar share of young, medium-aged and old companies.
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FIGURE 7.10 - PERCENTAGE OF M&A DEALS BY TARGET AGE GROUP AND ACQUIRER REGION.
We conclude this analysis by investigating the cross-
border M&A activities targeting young firms in the EU 
and the US. Figure 7.11 reports the number of deals 
concerning young US and EU target with high, medium 
and low levels of R&D intensity. In general, the shares 
of cross-border M&A are smaller than the national M&A 
ones, except for young companies with a medium-low 
level of R&D intensity. As for the “cherry-picking” of young 
and high R&D intensive firms, the figure shows that in 
relative terms, the EU is picking roughly the same amount 
of cherries in the US than the US in the EU (22% versus 
19% respectively). 
FIGURE 7.11 - M&A IN US AND EU BY TARGET R&D INTENSITY AND ACQUIRING COUNTRY.
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Examples of US Scoreboard companies acquiring EU 
targets are the acquisition of Torex, a UK-based European 
market leader for till systems by Micro Systems (a 
subsidiary of Oracle), as well as the acquisition of the 
Dutch hemodynamic monitoring solutions company 
BMEYE by Edwards Lifesciences Corporation for €32.5bn. 
On the other hand, the French company Nexans (optical 
fibre cable products) completed a strategic acquisition of 
the Valley Group (the world leader in the cable industry, 
in the field of real-time thermal rating technology for 
overhead power lines).
Another example is the recent acquisition of Dutch NXP 
Semiconductors by Qualcomm for €35.2bn, when in 
March 2015, NXP made its own deal, buying a US smaller 
peer, Freescale Semiconductor, for €10.8bn.
ANNEXES
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Investment in research and innovation is at the core of 
the EU policy agenda. The Europe 2020 growth strategy 
includes the Innovation Union flagship initiative21 with 
a 3 % headline target for intensity of research and 
development (R&D)22. 
R&D investment from the private sector plays also a key 
role for other relevant Europe 2020 initiatives such as the 
Industrial Policy23, Digital Agenda and New Skills for New 
Jobs flagship initiatives. 
The Industrial Research and Innovation Monitoring and 
Analysis (IRIMA) project24 supports policymakers in these 
initiatives and monitors progress towards the 3 % headline 
target. The Scoreboard, as part of the IRIMA project, aims 
to improve the understanding of trends in R&D investment 
by the private sector and the factors affecting it. 
The annual publication of the Scoreboard is intended to 
raise awareness of the importance of R&D for businesses 
and to encourage firms to disclose information about their 
R&D investments and other intangible assets.
The data for the Scoreboard are taken from companies’ 
publicly available audited accounts. As in more than 99% 
of cases these accounts do not include information on the 
place where R&D is actually performed, the company’s 
whole R&D investment in the Scoreboard is attributed 
to the country in which it has its registered office25. This 
should be borne in mind when interpreting the Scoreboard’s 
country classifications and analyses. 
The Scoreboard’s approach is, therefore, fundamentally 
different from that of statistical offices or the OECD when 
preparing Business Enterprise Expenditure on R&D (BERD) 
data, which are specific to a given territory26. The Scoreboard 
data are primarily of interest to those concerned with 
benchmarking company commitments and performance (e.g. 
companies, investors and policymakers), while BERD data are 
primarily used by economists, governments and international 
organisations interested in the R&D performance of territorial 
units defined by political boundaries. The two approaches 
are therefore complementary. The methodological approach 
of the Scoreboard, its scope and limitations are further 
detailed in Annex 2 below.
21 The Innovation Union flagship initiative aims to strengthen knowledge and innovation as drivers of future growth by refocusing R&D and innovation policies for the main 
challenges society faces. 
22 This target refers to the EU's overall (public and private) R&D investment approaching 3 % of gross domestic product (see: http://ec.europa.eu/europe2020/pdf/targets_en.pdf). 
23 The Industrial Policy for the Globalisation Era flagship initiative aims to improve the business environment, notably for small and medium-sized enterprises, and support the 
development of a strong and sustainable industrial foundation for global competition. 
24 See: http://iri.jrc.ec.europa.eu/home /. The activity is undertaken jointly by the Directorate General for Research (DG RTD A; see: http://ec.europa.eu/research/index.cfm?lg=en) 
and the Joint Research Centre, Institute for Prospective Technological Studies (JRC-IPTS; see: https://ec.europa.eu/jrc/en/science-area/innovation-and-growth).  
25 The registered office is the company address notified to the official company registry. It is normally the place where a company's books are kept. 
26 The Scoreboard refers to all R&D financed by a company from its own funds, regardless of where the R&D is performed. BERD refers to all R&D activities performed by busi-
nesses within a particular sector and territory, regardless of the location of the business’s headquarters, and regardless of the sources of finance. The sources of data also differ: 
the Scoreboard collects data from audited financial accounts and reports whereas BERD typically takes a stratified sample, covering all large companies and a representative 
sample of smaller companies. Additional differences concern the definition of R&D intensity (BERD uses the percentage of R&D in value added, while the Scoreboard considers 
the R&D/Sales ratio) and the sectoral classification (BERD uses NACE (the European statistical classification of economic sectors), while the Scoreboard uses the ICB (the Interna-
tional Classification Benchmark). 
27 According to latest Eurostat statistics. 
Background informationA .1
Scope and target audience
The Scoreboard is a benchmarking tool which provides 
reliable up-to-date information on R&D investment 
and other economic and financial data, with a unique 
EU-focus. The 2500 companies listed in this year’s 
Scoreboard account for more than 90%27 of worldwide 
business enterprise expenditure on R&D (BERD). 
Furthermore, the dataset is extended to cover the top 
1000 R&D investing companies in the EU. 
The data in the Scoreboard, published since 2004, allow 
long-term trend analyses, for instance, to examine links 
between R&D and business performance. The Scoreboard 
is aimed at three main audiences.
• Companies can use the Scoreboard to benchmark their 
R&D investments and so find where they stand in the EU 
and in the global industrial R&D landscape. This informa-
tion could be of value in shaping business or R&D strategy. 
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• Investors and financial analysts can use the Scoreboard 
to assess sectoral trends and investment opportunities 
and risks.
• Policy-makers, government and business organisa-
tions can use R&D investment information as an 
input to policy formulation or other R&D-related 
actions. 
Furthermore, the Scoreboard dataset has been made 
freely accessible so as to encourage further economic and 
financial analyses and research by any interested parties.
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The data for the 2016 EU Industrial R&D Scoreboard 
(the Scoreboard) have been collected from companies' 
annual reports and accounts by Bureau van Dijk Electronic 
Publishing GmbH (BvD). The source documents, annual 
reports & accounts, are public domain documents and so the 
Scoreboard is capable of independent replication. In order 
to ensure consistency with our previous Scoreboards, BvD 
data for the years prior to 2012 have been checked with the 
corresponding data of the previous Scoreboards adjusted 
for the corresponding exchange rates of the annual reports. 
Main characteristics of the data
The data correspond to companies' latest published 
accounts, intended to be their 2015 fiscal year accounts, 
although due to different accounting practices throughout 
the world, they also include accounts ending on a range 
of dates between late 2014 and mid-2016. Furthermore, 
the accounts of some companies are publicly available 
more promptly than others. Therefore, the current set 
represents a heterogeneous set of timed data.
In order to maximise completeness and avoid double 
counting, the consolidated group accounts of the 
ultimate parent company are used. Companies which 
are subsidiaries of any other company are not listed 
separately. Where consolidated group accounts of the 
ultimate parent company are not available, subsidiaries 
are included.
In case of a demerger, the full history of the continuing 
entity is included. The history of the demerged company 
can only go back as far as the date of the demerger to 
avoid double counting of figures.
In case of an acquisition or merger, pro forma figures for 
the year of acquisition are used along with pro-forma 
comparative figures if available. 
The R&D investment included in the Scoreboard is the cash 
investment which is funded by the companies themselves. 
It excludes R&D undertaken under contract for customers 
such as governments or other companies. It also excludes 
the companies' share of any associated company or joint 
venture R&D investment when disclosed. Where part or all 
of R&D costs have been capitalised, the additions to the 
appropriate intangible assets are included to calculate the 
cash investment and any amortisation eliminated.
Companies are allocated to the country of their registered 
office. In some cases this is different from the operational 
or R&D headquarters. This means that the results are 
independent of the actual location of the R&D activity. 
Companies are in industry sectors according to the NACE 
Rev. 228 and the ICB (Industry Classification Benchmark).
28 NACE is the acronyme for “Nomenclature statistique des activités économiques dans la Communauté européenne”.
Methodological notesA .2
Limitations
The Scoreboard relies on disclosure of R&D investment 
in published annual reports and accounts. Therefore, 
companies which do not disclose figures for R&D 
investment or which disclose only figures which are not 
material enough are not included in the Scoreboard. 
Due to different national accounting standards and 
disclosure practice, companies of some countries are 
less likely than others to disclose R&D investment 
consistently. 
In some countries, R&D costs are very often integrated with 
other operational costs and can therefore not be identified 
separately. For example, companies from many Southern 
European countries or the new Member States are under-
represented in the Scoreboard. On the other side, UK 
companies are over-represented in the Scoreboard. 
For listed companies, country representation will improve 
with IFRS adoption.
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Interpretation
There are some fundamental aspects of the Scoreboard 
which affect their interpretation.
The focus of the Scoreboard on R&D investment as 
reported in group accounts means that the results can 
be independent of the location of the R&D activity. 
The Scoreboard indicates the level of R&D funded by 
companies, not all of which is carried out in the country in 
which the company is registered. This enables inputs such 
as R&D and Capex investment to be related to outputs 
such as Sales, Profits, productivity ratios and market 
capitalisation. 
The data used for the Scoreboard are different from 
data provided by statistical offices, e.g. BERD data. The 
Scoreboard refers to all R&D financed by a particular 
company from its own funds, regardless of where 
that R&D activity is performed. BERD refers to all R&D 
activities performed by businesses within a particular 
sector and territory, regardless of the location of the 
business’s headquarters, and regardless of the sources 
of finance. 
Further, the Scoreboard collects data from audited 
financial accounts and reports. BERD typically takes a 
stratified sample, covering all large companies and a 
representative sample of smaller companies. Additional 
differences concern the definition of R&D intensity 
(BERD uses the percentage of value added, while the 
Scoreboard measures it as the R&D/Sales ratio) and the 
sectoral classification they use (BERD follows NACE, the 
European statistical classification of economic sectors, 
while the Scoreboard classifies companies’ economic 
activities according to the ICB classification).
Sudden changes in R&D figures may arise because 
of acquisitions, divestments or a change in company 
accounting standards. For example, the first time adoption 
of IFRS29, may lead to information discontinuities due to 
the different treatment of R&D, i.e. R&D capitalisation 
criteria are stricter and, where the criteria are met, the 
amounts must be capitalised. 
For many highly diversified companies, the R&D 
investment disclosed in their accounts relates only to 
part of their activities, whereas sales and profits are in 
respect of all their activities. Unless such groups disclose 
their R&D investment additional to the other information 
in segmental analyses, it is not possible to relate the R&D 
more closely to the results of the individual activities 
which give rise to it. The impact of this is that some 
statistics for these groups, e.g. R&D as a percentage of 
sales, are possibly underestimated and so comparisons 
with non-diversified groups are limited.
29 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (International Financial Repor-
ting Standards, see: http://www.iasb.org/). 
The R&D investment disclosed in some companies' 
accounts follows the US practice of including engineering 
costs relating to product improvement. Where these 
engineering costs have been disclosed separately, they 
have been excluded from the Scoreboard. However, the 
incidence of non-disclosure is uncertain and the impact 
of this practice is a possible overstatement of some 
overseas R&D investment figures in comparison with 
the EU. 
Where R&D income can be clearly identified as a result of 
customer contracts it is deducted from the R&D expense 
stated in the annual report, so that the R&D investment 
included in the Scoreboard excludes R&D undertaken 
under contract for customers such as governments or 
other companies. However, the disclosure practise differs 
and R&D income from customer contracts cannot always 
be clearly identified. This means a possible overstatement 
of some R&D investment figures in the Scoreboard for 
companies with directly R&D related income where this is 
not disclosed in the annual report.
In implementing the definition of R&D, companies exhibit 
variability arising from a number of sources: i) different 
interpretations of the R&D definition. Some companies 
view a process as an R&D process while other companies 
may view the same process as an engineering or other 
process; ii) different companies' information systems for 
measuring the costs associated with R&D processes; iii) 
different countries' fiscal treatment of costs.
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At the aggregate level, the growth statistics reflect the 
growth of the set of companies in the current year set. 
Companies which may have existed in the base year but 
which are not represented in the current year set are not 
part of the Scoreboard (a company may continue to be 
represented in the current year set if it has been acquired 
by or merged with another). 
For companies outside the Euro area, all currency 
amounts have been translated at the Euro exchange 
rates ruling at 31 December 2015 as shown in Table 
A3.1. The exchange rate conversion also applies to the 
historical data. The result is that over time the Scoreboard 
reflects the domestic currency results of the companies 
rather than economic estimates of current purchasing 
parity results. The original domestic currency data can be 
derived simply by reversing the translations at the rates 
above. Users can then apply their own preferred current 
purchasing parity transformation models.
country as of 31 dec 2014 as of 31 dec 2015
Australia $ 1.48 $ 1.49
Brazil 3.22 Brazilian real 4.25 Brazilian real
Canada $ 1.41 $ 1.51
China 7.43 Renminbi 7.07 Renminbi
Czech Republic 27.72 Koruna 27.03 Koruna
Denmark 7.43 Danish Kronor 7.44 Danish Kronor
Hungary 314.46 Forint 312.50 Forint
India 76.86 Indian Rupee 72.20 Indian Rupee
Israel 4.72 Shekel 4.25 Shekel
Japan 146.41 Yen 131.23 Yen
Mexico 17.87 Mexican Peso 18.73 Mexican Peso
Norway 9.02 Norwegian Kronor 9.59 Norwegian Kronor
Poland 4.06 Zloty 4.25 Zloty
Russia 68.31 Rouble 79.37 Rouble
South Korea 1 333.33 Won 1 282.05 Won
Sweden 9.39 Swedish Kronor 9.19 Swedish Kronor
Switzerland 1.20 Swiss Franc 1.08 Swiss Franc
Turkey 2.82 Turkish Lira 3.17 Turkish Lira
UK £ 0.78 £ 0.73
USA $ 1.21 $ 1.09
Taiwan $ 40.02 $ 35.88
TABLE A3.1. EURO EXCHANGE RATES APPLIED TO SCOREBOARD DATA OF COMPANIES BASED IN DIFFERENT CURRENCY AREAS (AS OF 31 DEC 2015).
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Glossary of definitions
Research and Development (R&D) investment in the Scoreboard is the cash investment funded by the 
companies themselves. It excludes R&D undertaken under contract for customers such as governments or other 
companies. It also excludes the companies' share of any associated company or joint venture R&D investment. 
Being that disclosed in the annual report and accounts, it is subject to the accounting definitions of R&D. For 
example, a definition is set out in International Accounting Standard (IAS) 38 “Intangible assets” and is based 
on the OECD “Frascati” manual. Research is defined as original and planned investigation undertaken with the 
prospect of gaining new scientific or technical knowledge and understanding. Expenditure on research is recognised 
as an expense when it is incurred. Development is the application of research findings or other knowledge to 
a plan or design for the production of new or substantially improved materials, devices, products, processes, 
systems or services before the start of commercial production or use. Development costs are capitalised when 
they meet certain criteria and when it can be demonstrated that the asset will generate probable future economic 
benefits. Where part or all of R&D costs have been capitalised, the additions to the appropriate intangible assets 
are included to calculate the cash investment and any amortisation eliminated.
Net sales follow the usual accounting definition of sales, excluding sales taxes and shares of sales of joint 
ventures & associates. For banks, sales are defined as the “Total (operating) income” plus any insurance income. 
For insurance companies, sales are defined as “Gross premiums written” plus any banking income.
R&D intensity is the ratio between R&D investment and net sales of a given company or group of companies. 
At the aggregate level, R&D intensity is calculated only by those companies for which data exist for both R&D and 
net sales in the specified year. The calculation of R&D intensity in the Scoreboard is different from than in official 
statistics, e.g. BERD, where R&D intensity is based on value added instead of net sales. 
Operating profit is calculated as profit (or loss) before taxation, plus net interest cost (or minus net interest 
income) minus government grants, less gains (or plus losses) arising from the sale/disposal of businesses or fixed 
assets.
One-year growth is simple growth over the previous year, expressed as a percentage: 1 yr growth = 100*((C/B)-
1); where C = current year amount, and B = previous year amount. 1yr growth is calculated only if data exist for 
both the current and previous year. At the aggregate level, 1yr growth is calculated only by aggregating those 
companies for which data exist for both the current and previous year.
Three-year growth is the compound annual growth over the previous three years, expressed as a percentage: 
3 yr growth = 100*(((C/B)^(1/t))-1); where C = current year amount, B = base year amount (where base year = 
current year - 3), and t = number of time periods (= 3). 3yr growth is calculated only if data exist for the current 
and base years. At the aggregate level, 3yr growth is calculated only by aggregating those companies for which 
data exist for the current and base years. 
Capital expenditure (Capex) is expenditure used by a company to acquire or upgrade physical assets such 
as equipment, property, industrial buildings. In accounts capital expenditure is added to an asset account (i.e. 
capitalised), thus increasing the asset's base. It is disclosed in accounts as additions to tangible fixed assets.
Number of employees is the total consolidated average employees or year-end employees if average not 
stated.
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The analysis of chapter 4 applies an extended sample 
of 1000 companies based in the EU. It consists of 590 
companies included in the world R&D ranking of top 2500 
companies and additional 410 companies also ranked by 
level of R&D investment. The composition by country and 
industry of the EU 1000 sample is presented in the table 
A3.1 below.
Composition of the EU 1000 sampleA .3
industry eu country codes
icb 3-d at be cw cz de dk es fi fr gr hu ie it lu mt nl pl pt ro se si uk total
Aerospace & 
Defence 1 2 1 7 2 1 1 9 24
Alternative Energy 4 1 1 0 6
Automobiles & 
Parts 4 18 1 6 5 2 2 9 47
Banks 2 7 2 2 2 1 2 2 2 2 2 7 33
Beverages 1 1 2
Chemicals 2 3 14 1 3 3 3 3 10 42
Construction & 
Materials 2 5 1 7 1 4 2 4 2 2 2 1 3 36
Electricity 1 1 1 1 2 2 2 2 1 1 4 18
Electr. & Electrical 
equipment 3 3 14 2 4 9 1 4 1 5 4 19 69
Financial Services 6 1 1 1 4 4 17
Fixed Line 
Telecommunications 1 1 1 1 1 1 1 1 2 10
Food & Drug 
Retailers 1 2 3
Food Producers 1 2 1 2 3 2 2 5 8 26
Forestry & Paper 3 1 1 3 2 10
Gas, Water & 
Multi-utilities 1 2 3 1 2 9
General Industrials 1 10 1 1 1 2 1 2 2 2 7 5 35
General Retailers 3 5 8
Health Care 
Equipment & 
Services
2 1 13 3 3 2 2 5 13 44
Household Goods 
& Home Const. 5 1 2 2 1 3 1 4 19
TABLE A3.1 - DISTRIBUTION OF THE SAMPLE OF 1000 COMPANIES BASED IN THE EU BY COUNTRY AND INDUSTRY.  
TABLE CONTINUES ON NEXT PAGE →
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industry eu country codes
icb 3-d at be cw cz de dk es fi fr gr hu ie it lu mt nl pl pt ro se si uk total
Industrial Engineering 5 2 37 3 3 7 7 2 7 2 4 11 14 104
Industrial Metals & 
Mining 2 3 5 1 1 1 2 1 2 0 18
Industrial 
Transportation 1 1 1 3 2 1 1 10
Leisure Goods 2 1 1 1 5
Media 4 1 2 6 13
Mining 1 2 3 6
Mobile 
Telecommunications 1 1 1 1 4
Oil & Gas Producers 1 1 1 1 1 1 2 8
Oil Equipment, 
Services & Distrib. 2 1 1 1 1 6
Personal Goods 1 6 3 4 1 0 15
Pharmaceuticals & 
Biotechnology 1 5 14 11 4 1 20 1 1 8 4 1 8 1 9 1 43 133
Real Estate Investment 
& Services 3 1 1 5
Software & Computer 
Services 2 20 2 2 5 17 1 1 3 1 5 53 112
Support Services 12 3 1 1 6 26 49
Technology Hardware 
& Equip. 2 1 6 1 2 6 1 1 6 5 10 41
Tobacco 1 1 2
Travel & Leisure 1 3 1 1 1 1 3 11
TOTAL 29 30 2 3 217 34 22 39 117 5 1 25 43 15 1 49 1 5 1 83 3 275 1000
TABLE A3.1 - DISTRIBUTION OF THE SAMPLE OF 1000 COMPANIES BASED IN THE EU BY COUNTRY AND INDUSTRY.
105The 2016 EU Industrial R&D Scoreboard
Access to the full datasetA .4
The 2016 Scoreboard comprises two data samples:
• The world’s top 2500 companies that invested more than €21 million in R&D in 2015.
• The top 1000 R&D investing companies based in the EU with R&D investment exceeding €6 million.
 For each company the following information is available: 
• Company identification (name, country of registration and sector of declared activity according to ICB 
classifications).
• R&D investment 
• Net Sales 
• Capital expenditure 
• Operating profit or loss 
• Total number of employees
• Main company indicators (R&D intensity, Capex intensity, Profitability)
• Growth rates of main indicators over one year and three years.
The following links provide access to the two Scoreboard data samples containing the main economic and financial 
indicators and main statistics over the past four years.
R&D ranking of world top 2500 companies
R&D ranking of EU top 1000 companies
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